USPatent applicationPatented

Cyclohexenonquinolinoyl-derivatives as herbicidal agents

Granted 18 Apr 2006 · 6 office actions

Current assignee: BASF Aktiengesellschaft · originally BASF SE

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Wolfgang von Deyn, Guido Mayer, Ulf Neidlein, Roland Götz +10 · Examiner: Celia Chang · AU 1625 · TC 1600

Application· this page
9763704
filed 27 Aug 1999
Publication
Not published
not published
Patent
US 7,030,063
granted 18 Apr 2006

Life of the application

18 dated events
⤢ drag to zoom20002002200420062008201020122014201620182020ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

Cyclohexenonequinolinoyl derivatives of the formula I [structure] where: R 1 is hydrogen, nitro, halogen, cyano, alkyl, haloalkyl, alkoxyiminomethyl, alkoxy, haloalkoxy, alkylthio, C 1 –C 6 -haloalkylthio, alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl, haloalkylsulfonyl, unsubstituted or substituted amino sulfonyl, unsubstituted or substituted sulfonyl amino, unsubstituted or substituted phenoxy, unsubstituted or substituted heterocyclyloxy, unsubstituted or substituted phenylthio or unsubstituted or substituted heterocyclylthio; R 2 , R 3 are hydrogen, alkyl, haloalkyl or halogen; R 4 is substituted (3-oxo-1-cyclohexen-2-yl)carbonyl or substituted (1,3-dioxo-2-cyclohexyl)methylidene; and their agriculturally useful salts; processes for preparing the cyclohexenonequinolinoyl derivatives; compositions comprising them, and the use of these derivatives or compositions comprising them for controlling undesirable plants are described.

Description

21 parts
›The present invention relates to novel cyclohexenonequinolinoyl derivatives…

The present invention relates to novel cyclohexenonequinolinoyl derivatives of the formula I,

where:

R 1 is hydrogen, nitro, halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, C 1 –C 6 -alkoxyiminomethyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfinyl, C 1 –C 6 -haloalkylsulfinyl, C 1 –C 6 -alkylsulfonyl, C 1 –C 6 -haloalkylsulfonyl, aminosulfonyl, N—(C 1 –C 6 -alkyl)aminosulfonyl, N,N-di-(C 1 –C 6 -alkyl)aminosulfonyl, N—(C 1 –C 6 -alkylsulfonyl)amino, N—(C 1 –C 6 -haloalkylsulfonyl)amino, N—(C 1 –C 6 -alkyl)-N-(C 1 –C 6 -alkylsulfonyl)amino, N—(C 1 –C 6 -alkyl)-N-(C 1 –C 6 -haloalkylsulfonyl) amino, phenoxy, heterocyclyloxy, phenylthio or heterocyclylthio, where the four last-mentioned radicals may be partially or fully halogenated and/or may carry one to three of the following substituents:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 2 , R 3 are hydrogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl or halogen; R 4 is a compound IIa or IIb

where

R 5 is halogen, OR 7 , SR 7 , SOR 8 , SO 2 R 8 , OSO 2 R 8 , POR 8 R 9 , OPR 8 R 9 , OPOR 8 R 9 , OPSR 8 R 9 , NR 10 R 11 , ONR 11 R 12 , N-linked heterocyclyl or O—(N-linked heterocyclyl), where the heterocyclyl radical of the two last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 6 is nitro, halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, di-(C 1 –C 6 -alkoxy)methyl, di-(C 1 –C 6 -alkylthio)methyl, (C 1 –C 6 -alkoxy)(C 1 –C 6 -alkylthio)methyl, hydroxy, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkoxycarbonyloxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfinyl, C 1 –C 6 -haloalkylsulfinyl, C 1 –C 6 -alkylsulfonyl, C 1 –C 6 -haloalkylsulfonyl, C 1 –C 6 -alkylcarbonyl, C 1 –C 6 -haloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl or C 1 –C 6 -haloalkoxycarbonyl; or two radicals R 6 , which are linked to the same carbon, together form an —O—(CH 2 ) m , —O—(CH 2 ) m —S—, —S—(CH 2 ) m —S—, —O—(CH 2 ) n — or —S—(CH 2 ) n chain which may be substituted by one to three radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl; or

two radicals R 6 , which are linked to the same carbon, together form a —(CH 2 ) p chain which may be interrupted by oxygen or sulfur and/or may be substituted by one to four radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl;

or two radicals R 6 , which are linked to the same carbon, together form a methylidene group which may be substituted by one or two radicals from the following group:

halogen, hydroxyl, formyl, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfinyl, C 1 –C 6 -haloalkylsulfinyl, C 1 –C 6 -alkylsulfonyl or C 1 –C 6 -haloalkylsulfonyl;

or two radicals R 6 , which are linked to the same carbon, together with this carbon form a carbonyl group; or two radicals R 6 , which are linked to different carbons, together form a —(CH 2 ) n chain which may be substituted by one to three radicals from the following group:

halogen, C 1 –C 6 -alkyl, C 1 –C 6 -alkoxy, hydroxyl or C 1 –C 6 -alkoxycarbonyl;

R 7 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 3 –C 6 -haloalkynyl, C 3 –C 6 -cycloalkyl, C 1 –C 20 -alkylcarbonyl, C 2 –C 6 -alkenylcarbonyl, C 2 –C 6 -alkynylcarbonyl, C 3 –C 6 -Cycloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, C 3 –C 6 -alkenyloxycarbonyl, C 3 –C 6 -alkynyloxycarbonyl, (C 1 –C 20 -alkylthio)carbonyl, C 1 –C 6 -alkylaminocarbonyl, C 3 –C 6 -alkenylaminocarbonyl, C 3 –C 6 -alkynylaminocarbonyl, N, N-di-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkenyl) —N—(C 1 –C 6 -alkoxy) aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkoxy)aminocarbonyl, di-(C 1 –C 6 -alkyl)-aminothiocarbonyl, C 1 –C 6 -alkylcarbonyl-C 1 –C 6 -alkyl, C 1 –C 6 -alkoxyimino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl or N,N-di-(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, di-(C 1 –C 4 alkyl)amino, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, C 1 –C 4 -alkoxy-C 1 –C 4 -alkoxycarbonyl, di-(C 1 –C 4 -alkyl) amino-C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, C 1 –C 4 -alkylaminocarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, phenylcarbonyl, heterocyclylcarbonyl, phenoxycarbonyl, heterocyclyloxycarbonyl, phenoxythiocarbonyl, heterocyclyloxythiocarbonyl, phenoxy-C 1 –C 6 -alkylcarbonyl, heterocyclyloxy-C 1 –C 6 -alkylcarbonyl, phenylaminocarbonyl, N—(C 1 –C 6 -alkyl)-N-(phenyl)aminocarbonyl, heterocyclylaminocarbonyl, N—(C 1 –C 6 -alkyl)-N-(heterocyclyl) aminocarbonyl, phenyl-C 2 –C 6 -alkenylcarbonyl or heterocyclyl-C 2 –C 6 -alkenylcarbonyl, where the phenyl and the heterocyclyl radical of the 20 last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 8 , R 9 are C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 3 –C 6 -haloalkynyl, C 3 –C 6 -Cycloalkyl, hydroxyl, C 1 –C 6 -alkoxy, amino, C 1 –C 6 -alkylamino, C 1 –C 6 -haloalkylamino, di-(C 1 –C 6 alkyl)amino or di-(C 1 –C 6 -haloalkyl)amino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups:

›cyano, C 1 –C 4 -alkoxy, C 1…

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, di-(C 1 –C 4 alkyl)amino, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, C 1 –C 4 -alkoxy-C 1 –C 4 -alkoxycarbonyl, di-(C 1 –C 4 -alkyl)amino-C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, C 1 –C 4 -alkylaminocarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenoxy, heterocyclyloxy, where the phenyl and the heterocyclyl radical of the last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 10 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 3 –C 6 -haloalkynyl, C 3 –C 6 -cycloalkyl, hydroxyl, C 1 –C 6 -alkoxy, C 3 –C 6 -alkenyloxy, C 3 –C 6 -alkynyloxy, amino, C 1 –C 6 -alkylamino, di-(C 1 –C 6 -alkyl)amino or C 1 –C 6 -alkylcarbonylamino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three radicals from the following group:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, di-(C 1 –C 4 -alkyl)amino, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, C 1 –C 4 -alkoxy-C 1 –C 4 -alkoxycarbonyl, di-(C 1 –C 4 -alkyl)amino-C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, C 1 –C 4 -alkylaminocarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl or heterocyclyl-C 1 –C 6 -alkyl, where the phenyl or heterocyclyl radical of the four last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 11 , R 12 are C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -alkynyl or C 1 –C 6 -alkylcarbonyl; l is 0 to 6; m is 2 to 4; n is 1 to 5; p is 2 to 5;

and their agriculturally useful salts.

Moreover, the invention relates to processes for preparing compounds of the formula I, to compositions comprising them and to the use of these derivatives or the compositions comprising them for controlling harmful plants.

The literature, for example WO 98/12 180 and EP-A 283 261, discloses quinolinoyl or fused phenyl derivatives which are linked to an unsubstituted or substituted (1-hydroxy-3-oxo-cyclohex-1-en-2-yl)carbonyl radical. However, the herbicidal properties of the prior art compounds and their compatibility with crop plants are not entirely satisfactory.

It is an object of the present invention to provide other biologically, in particular herbicidally, active compounds.

We have found that this object is achieved by the cyclohexenonequinolinoyl derivatives of the formula I and their herbicidal action.

Furthermore, we have found herbicidal compositions which comprise the compounds I and have very good herbicidal action. Moreover, we have found processes for pr paring these compositions and methods for controlling undesirable vegetation using the compounds I.

Depending on the substitution pattern, the compounds of the formula I may contain one or more chiral centers, in which case they are present as enantiomers or mixtures of diastereomers. The invention provides both the pure enantiomers or diastereomers and their mixtures.

The compounds of the formula I may also be present in the form of their agriculturally useful salts, where the type of salt is usually immaterial. In general, the salts of those cations and the acid addition salts of those acids are suitable whose cations and anions, respectively, do not negatively affect the herbicidal action of the compounds I.

Suitable cations are, in particular, ions of the alkali metals, preferably lithium, sodium and potassium, of the alkaline earth metals, preferably calcium and magnesium, and of the transition metals, preferably manganese, copper, zinc and iron, and also ammonium, where, if desired, one to four hydrogen atoms may be replaced by C 1 –C 4 -alkyl, hydroxy-C 1 –C 4 -alkyl, C 1 –C 4 -alkoxy-C 1 –C 4 -alkyl, hydroxy-C 1 –C 4 -alkoxy-C 1 –C 4 -alkyl, phenyl or benzyl, preferably ammonium, dimethylammonium, diisopropylammonium, tetramethylammonium, tetrabutylammonium, 2-(2-hydroxyeth-1-oxy)eth-1-ylammonium, di(2-hydroxyeth-1-yl)ammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(C 1 –C 4 -alkyl)sulfonium and sulfoxonium ions, preferably tri(C 1 –C 4 -alkyl)sulfoxonium.

Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, nitrate, hydrogen carbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and also the anions of C 1 –C 4 -alkanoic acids, preferably formate, acetate, propionate and butyrate.

The organic moieties mentioned for the substituents R 1 –R 12 or as radicals on phenyl and heterocyclyl radicals are collective terms for individual enumerations of the particular group members. All hydrocarbon chains, i.e. all alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, haloalkylthio, alkylsulfynyl, haloalkylsulfynyl, alkylsulfonyl, haloalkylsulfonyl, N-alkylaminosulfonyl, N,N-dialkylaminosulfonyl, N-alkylamino, N,N-dialkylamino, N-haloalkylamino, N-alkoxyamino, N-alkoxy-N-alkylamino, N-alkylcarbonylamino, N-alkylsulfonylamino, N-haloalkylsulfonylamino, N-alkyl-N-alkylsulfonylamino, N-alkyl-N-haloalkylsulfonylamino, alkylcarbonyl, haloalkylcarbonyl, alkoxycarbonyl, haloalkoxycarbonyl, alkylthiocarbonyl, alkylcarbonyloxy, alkylaminocarbonyl, dialkylaminocarbonyl, dialkylaminothiocarbonyl, alkoxyalkyl, dialkoxymethyl, dialkylthiomethyl, (alkoxy)(alkylthio)methyl, alkylcarbonylalkyl, alkoxyiminomethyl, alkoxyiminoalkyl, N-(alkylamino)iminoalkyl, N-(dialkylamino)iminoalkyl, phenylalkenylcarbonyl, heterocyclylalkenylcarbonyl, phenoxyalkylcarbonyl, heterocyclyloxyalkylcarbonyl, N-alkoxy-N-alkylaminocarbonyl, N-alkyl-N-phenylaminocarbonyl, N-alkyl-N-heterocyclylaminocarbonyl, alkoxycarbonyloxy, phenylalkyl, heterocyclylalkyl, phenylcarbonylalkyl, heterocyclylcarbonylalkyl, dialkylaminoalkoxycarbonyl, alkoxyalkoxycarbonyl, alkenylcarbonyl, alkenyloxycarbonyl, alkenylaminocarbonyl, N-alkenyl-N-alkylaminocarbonyl, N-alkenyl-N-alkoxyaminocarbonyl, alkynylcarbonyl, alkynyloxycarbonyl, alkynylaminocarbonyl, N-alkynyl-N-alkylaminocarbonyl, N-alkynyl-N-alkoxyaminocarbonyl, alkenyl, alkynyl, haloalkenyl, haloalkynyl, alkenyloxy, alkynyloxy and alkoxyalkoxy moieties, may be straight-chain or branched. Unless indicated otherwise, halogenated substituents preferably carry one to five identical or different halogen atoms. The term “halogen” in each case represents fluorine, chlorine, bromine or iodine.

›Examples of other meanings are: C 1 –C…

Examples of other meanings are:

C 1 –C 4 -alkyl: for example methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl or 1,1-dimethylethyl; C 1 –C 6 -alkyl, and the alkyl moieties of C 1 –C 6 -alkoxyimino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl, N-(di-C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl)-aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, (C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 1 –C 6 -alkyl)-N-phenylaminocarbonyl, N—(C 1 –C 6 -alkyl)-N-heterocyclylaminocarbonyl, phenyl-1–C 6 -alkyl, N—(C 1 –C 6 -alkyl)-N-(C 1 –C 6 -alkylsulfonyl)amino, N—(C 1 –C 6 -alkyl)-N(C 1 –C 6 -haloalkylsulfonyl)amino, heterocyclyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl: C 1 –C 4 -alkyl as mentioned above, and also, for example, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1-ethyl-1-methylpropyl or 1-ethyl-3-methylpropyl; C 1 –C 4 -haloalkyl: a C 1 –C 4 -alkyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-pentafluoropropyl, heptafluoropropyl, 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl or nonafluorobutyl; C 1 –C 6 -haloalkyl, and the haloalkyl moieties of N—C 1 –C 6 -haloalkylamino: C 1 –C 4 -haloalkyl, as mentioned above, and also, for example, 5-fluoropentyl, 5-chloropentyl, 5-bromopentyl, 5-iodopentyl, undecafluoropentyl, 6-fluorohexyl, 6-chlorohexyl, 6-bromohexyl, 6-iodohexyl or dodecafluorohexyl; C 1 –C 4 -alkoxy: for example methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy; C 1 –C 6 -alkoxy, and the alkoxy moieties of N—C 1 –C 6 -alkoxyamino, di-(C 1 –C 6 -alkoxy)methyl, (C 1 –C 6 -alkoxy)(C 1 –C 6 -alkylthio)-methyl, C 1 –C 6 -alkoxyiminomethyl, C 1 –C 6 -alkoxyimino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkoxy)aminocarbonyl and N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkoxy)aminocarbonyl: C 1 –C 4 -alkoxy as mentioned above, and also, for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy; C 1 –C 4 -haloalkoxy: a C 1 –C 4 -alkoxy radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromomethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2,3-dichloropropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, 2,2,3,3,3-pentafluoropropoxy, heptafluoropropoxy, 1-(fluoromethyl)-2-fluoroethoxy, 1-(chloromethyl)-2-chloroethoxy, 1-(bromomethyl)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy; C 1 –C 6 -haloalkoxy: C 1 –C 4 -haloalkoxy as mentioned above, and also, for example, 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy; C 1 –C 4 -alkylthio: for example methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio or 1,1-dimethylethylthio; C 1 –C 6 -alkylthio, and the alkylthio moieties of (C 1 –C 6 -alkylthio)carbonyl, di-(C 1 –C 6 -alkylthio)methyl and (C 1 –C 6 -alkoxy)-(C 1 –C 6 -alkylthio)methyl: C 1 –C 4 -alkylthio as mentioned above, and also, for example, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1-methylpropylthio or 1-ethyl-2-methylpropylthio; C 1 –C 20 -alkylthio as alkylthio radical of (C 1 –C 20 -alkylthio)carbonyl: C 1 –C 6 -alkylthio as mentioned above, and also, for example, heptylthio, octylthio, hexadecylthio or octadecylthio; C 1 –C 4 -haloalkylthio: a C 1 –C 4 -alkylthio radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2,2,2-trichloroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, pentafluoroethylthio, 2-fluoropropylthio, 3-fluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 2,2-difluoropropylthio, 2,3-difluoropropylthio, 2,3-dichloropropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, 2,2,3,3,3-pentafluoropropylthio, heptafluoropropylthio, 1-(fluoromethyl)-2-fluoroethylthio, 1-(chloromethyl)-2-chloroethylthio, 1-(bromomethyl)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, 4-bromobutylthio or nonafluorobutylthio; C 1 –C 6 -haloalkylthio: C 1 –C 4 -haloalkylthio, as mentioned above, and also, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-bromopentylthio, 5-iodopentylthio, undecafluoropentylthio, 6-fluorohexylthio, 6-chlorohexylthio, 6-bromohexylthio, 6-iodohexylthio or dodecafluorohexylthio; C 1 –C 6 -alkylsulfinyl (C 1 –C 6 -alkyl-S(═O)—): for example methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, l-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl or 1-ethyl-2-methylpropylsulfinyl; C 1 –C 6 -haloalkylsulfinyl: a C 1 –C 6 -alkylsulfinyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, fluoromethylsulfinyl, difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl, 2-fluoroethylsulfinyl, 2-chloroethylsulfinyl, 2-bromoethylsulfinyl, 2-iodoethylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl, 2-chloro-2-fluoroethylsulfinyl, 2-chloro-2,2-difluoroethylsulfinyl, 2,2-dichloro-2-fluoroethylsulfinyl, pentafluoroethylsulfinyl, 2-fluoropropylsulfinyl, 3-fluoropropylsulfinyl, 2-chloropropylsulfinyl, 3-chloropropylsulfinyl, 2-bromopropylsulfinyl, 3-bromopropylsulfinyl, 2,2-difluoropropylsulfinyl, 2,3-difluoropropylsulfinyl, 2,3-dichloropropylsulfinyl, 3,3,3-trifluoropropylsulfinyl, 3,3,3-trichloropropylsulfinyl, 2,2,3,3,3-pentafluoropropylsulfinyl, heptafluoropropylsulfinyl, 1-(fluoromethyl)-2-fluoroethylsulfinyl, 1-(chloromethyl)-2-chloroethylsulfinyl, 1-(bromomethyl)-2-bromoethylsulfinyl, 4-fluorobutylsulfinyl, 4-chlorobutylsulfinyl, 4-bromobutylsulfinyl, nonafluorobutylsulfinyl, 5-fluoropentylsulfinyl, 5-chloropentylsulfinyl, 5-bromopentylsulfinyl, 5-iodopentylsulfinyl, undecafluoropentylsulfinyl, 6-fluorohexylsulfinyl, 6-chlorohexylsulfinyl, 6-bromohexylsulfinyl, 6-iodohexylsulfinyl or dodecafluorohexylsulfinyl; C 1 –C 6 -alkylsulfonyl (C 1 –C 6 -alkyl-S(═O) 2 —), and the alkylsulfonyl radicals of N—(C 1 –C 6 -alkylsulfonyl)amino and N—(C 1 –C 6 -alkyl)-N-(C 1 –C 6 -alkylsulfonyl)amino: for example, methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl or 1-ethyl-2-methylpropylsulfonyl; C 1 –C 6 -haloalkylsulfonyl, and the haloalkylsulfonyl radicals of N—(C 1 –C 6 -haloalkylsulfonyl)amino and N—(C 1 –C 6 -alkyl)-N-(C 1 –C 6 -haloalkylsulfonyl)amino: a C 1 –C 6 -alkylsulfonyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, fluoromethylsulfonyl, difluoromethylsulfonyl, trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl, 2-fluoroethylsulfonyl, 2-chloroethylsulfonyl, 2-bromoethylsulfonyl, 2-iodoethylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-chloro-2-fluoroethylsulfonyl, 2-chloro-2,2-difluoroethylsulfonyl, 2,2-dichloro-2-fluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl, pentafluoroethylsulfonyl, 2-fluoropropylsulfonyl, 3-fluoropropylsulfonyl, 2-chloropropylsulfonyl, 3-chloropropylsulfonyl, 2-bromopropylsulfonyl, 3-bromopropylsulfonyl, 2,2-difluoropropylsulfonyl, 2,3-difluoropropylsulfonyl, 2,3-dichloropropylsulfonyl, 3,3,3-trifluoropropylsulfonyl, 3,3,3-trichloropropylsulfonyl, 2,2,3,3,3-pentafluoropropylsulfonyl, heptafluoropropylsulfonyl, 1-(fluoromethyl)-2-fluoroethylsulfonyl, 1-(chloromethyl)-2-chloroethylsulfonyl, 1-(bromomethyl)-2-bromoethylsulfonyl, 4-fluorobutylsulfonyl, 4-chlorobutylsulfonyl, 4-bromobutylsulfonyl, nonafluorobutylsulfonyl, 5-fluoropentylsulfonyl, 5-chloropentylsulfonyl, 5-bromopentylsulfonyl, 5-iodopentylsulfonyl, 6-fluorohexylsulfonyl, 6-bromohexylsulfonyl, 6-iodohexylsulfonyl or dodecafluorohexylsulfonyl; C 1 –C 6 -alkylamino, and the alkylamino radicals of N—(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl: for example methylamino, ethylamino, propylamino, 1-methylethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1,1-dimethylethylamino, pentylamino, 1-methylbutylamino, 2-methylbutylamino, 3-methylbutylamino, 2,2-dimethylpropylamino, 1-ethylpropylamino, hexylamino, 1,1-dimethylpropylamino, 1,2-dimethylpropylamino, 1-methylpentylamino, 2-methylpentylamino, 3-methylpentylamino, 4-methylpentylamino, 1,1-dimethylbutylamino, 1,2-dimethylbutylamino, 1,3-dimethylbutylamino, 2,2-dimethylbutylamino, 2,3-dimethylbutylamino, 3,3-dimethylbutylamino, 1-ethylbutylamino, 2-ethylbutylamino, 1,1,2-trimethylpropylamino, 1,2,2-trimethylpropylamino, 1-ethyl-1-methylpropylamino or 1-ethyl-2-methylpropylamino; (C 1 –C 4 -alkylamino)sulfonyl: for example methylaminosulfonyl, ethylaminosulfonyl, propylaminosulfonyl, 1-methylethylaminosulfonyl, butylaminosulfonyl, 1-methylpropylaminosulfonyl, 2-methylpropylaminosulfonyl or 1,1-dimethylethylaminosulfonyl; (C 1 –C 6 -alkylamino)sulfonyl: (C 1 –C 4 -alkylamino)sulfonyl, as mentioned above, and also, for example, pentylaminosulfonyl, 1-methylbutylaminosulfonyl, 2-methylbutylaminosulfonyl, 3-methylbutylaminosulfonyl, 2,2-dimethylpropylaminosulfonyl, 1-ethylpropylaminosulfonyl, hexylaminosulfonyl, 1,1-dimethylpropylaminosulfonyl, 1,2-dimethylpropylaminosulfonyl, 1-methylpentylaminosulfonyl, 2-methylpentylaminosulfonyl, 3-methylpentylaminosulfonyl, 4-methylpentylaminosulfonyl, 1,1-dimethylbutylaminosulfonyl, 1,2-dimethylbutylaminosulfonyl, 1,3-dimethylbutylaminosulfonyl, 2,2-dimethylbutylaminosulfonyl, 2,3-dimethylbutylaminosulfonyl, 3,3-dimethylbutylaminosulfonyl, 1-ethylbutylaminosulfonyl, 2-ethylbutylaminosulfonyl, 1,1,2-trimethylpropylaminosulfonyl, 1,2,2-trimethylpropylaminosulfonyl, 1-ethyl-1-methylpropylaminosulfonyl or 1-ethyl-2-methylpropylaminosulfonyl; di-(C 1 –C 4 -alkyl)aminosulfonyl: for example N,N-dimethylaminosulfonyl, N,N-diethylaminosulfonyl, N,N-di-(1-methylethyl)aminosulfonyl, N,N-dipropylaminosulfonyl, N,N-dibutylaminosulfonyl, N,N-di-(1-methylpropyl)aminosulfonyl, N,N-di-(2-methylpropyl)aminosulfonyl, N,N-di-(1,1-dimethylethyl)aminosulfonyl, N-ethyl-N-methylaminosulfonyl, N-methyl-N-propylaminosulfonyl, N-methyl-N-(1-methylethyl)aminosulfonyl, N-butyl-N-methylaminosulfonyl, N-methyl-N-(1-methylpropyl)aminosulfonyl, N-methyl-N-(2-methylpropyl)aminosulfonyl, N-(1,1-dimethylethyl)-N-methylaminosulfonyl, N-ethyl-N-propylaminosulfonyl, N-ethyl-N-(1-methylethyl)aminosulfonyl, N-butyl-N-ethylaminosulfonyl, N-ethyl-N-(1-methylpropyl)aminosulfonyl, N-ethyl-N-(2-methylpropyl)aminosulfonyl, N-ethyl-N-(1,1-dimethylethyl)aminosulfonyl, N-(1-methylethyl)-N-propylaminosulfonyl, N-butyl-N-propyl aminosulfonyl, N-(1-methylpropyl)-N-propylaminosulfonyl, N-(2-methylpropyl)-N-propylaminosulfonyl, N-(1,1-dimethylethyl)-N-propylaminosulfonyl, N-butyl-N-(1-methylethyl)aminosulfonyl, N-(1-methylethyl)-N-(1-methylpropyl)aminosulfonyl, N-(1-methylethyl)-N-(2-methylpropyl)aminosulfonyl, N-(1,1-dimethylethyl)-N-(1-methylethyl)aminosulfonyl, N-butyl-N-(1-methylpropyl)aminosulfonyl, N-butyl-N-(2-methylpropyl)aminosulfonyl, N-butyl-N-(1,1-dimethylethyl)aminosulfonyl, N-(1-methylpropyl)-N-(2-methylpropyl)aminosulfonyl, N-(1,1-dimethylethyl)-N-(1-methylpropyl)aminosulfonyl or N-(1,1-dimethylethyl)-N-(2-methylpropyl)aminosulfonyl; di-(C 1 –C 6 -alkyl)aminosulfonyl: di-(C 1 –C 4 -alkyl)aminosulfonyl, as mentioned above, and also, for example, N-methyl-N-pentylaminosulfonyl, N-methyl-N-(1-methylbutyl)aminosulfonyl, N-methyl-N-(2-methylbutyl)aminosulfonyl, N-methyl-N-(3-methylbutyl)aminosulfonyl, N-methyl-N-(2,2-dimethylpropyl)aminosulfonyl, N-methyl-N-(1-ethylpropyl)aminosulfonyl, N-methyl-N-hexylaminosulfonyl, N-methyl-N-(1,1-dimethylpropyl)aminosulfonyl, N-methyl-N-(1,2-dimethylpropyl)aminosulfonyl, N-methyl-N-(1-methylpentyl)aminosulfonyl, N-methyl-N-(2-methylpentyl)aminosulfonyl, N-methyl-N-(3-methylpentyl)aminosulfonyl, N-methyl-N-(4-methylpentyl)aminosulfonyl, N-methyl-N-(1,1-dimethylbutyl)aminosulfonyl, N-methyl-N-(1,2-dimethylbutyl)aminosulfonyl, N-methyl-N-(1,3-dimethylbutyl)aminosulfonyl, N-methyl-N-(2,2-dimethylbutyl)aminosulfonyl, N-methyl-N-(2,3-dimethylbutyl)aminosulfonyl, N-methyl-N-(3,3-dimethylbutyl)aminosulfonyl, N-methyl-N-(1-ethylbutyl)aminosulfonyl, N-methyl-N-(2-ethylbutyl)aminosulfonyl, N-methyl-N-(1,1,2-trimethylpropyl)aminosulfonyl, N-methyl-N-(1,2,2-trimethylpropyl)aminosulfonyl, N-methyl-N-(1-ethyl-1-methylpropyl)aminosulfonyl, N-methyl-N-(1-ethyl-2-methylpropyl)aminosulfonyl, N-ethyl-N-pentylaminosulfonyl, N-ethyl-N-(1-methylbutyl)aminosulfonyl, N-ethyl-N-(2-methylbutyl)aminosulfonyl, N-ethyl-N-(3-methylbutyl)aminosulfonyl, N-ethyl-N-(2,2-dimethypropyl)aminosulfonyl, N-ethyl-N-(1,1-ethylpropyl)aminosulfonyl, N-ethyl-N-hexylaminosulfonyl, N-ethyl-N-(1,1-dimethylpropyl)aminosulfonyl, N-ethyl-N-(1,2-dimethyl propyl)aminosulfonyl, N-ethyl-N-(1-methylpentyl)aminosulfonyl, N-ethyl-N-(2-methylpentyl)aminosulfonyl, N-ethyl-N-(3-methylpentyl)aminosulfonyl, N-ethyl-N-(4-methylpentyl)aminosulfonyl, N-ethyl-N-(1,1-methylbutyl)aminosulfonyl, N-ethyl-N-(1,2-dimethylbutyl)aminosulfonyl, N-ethyl-N-(1,3-dimethylbutyl)aminosulfonyl, N-ethyl-N-(2,2-dimethylbutyl)aminosulfonyl, N-ethyl-N-(2,3-dimethylbutyl)aminosulfonyl, N-ethyl-N-(3,3-dimethylbutyl)aminosulfonyl, N-ethyl-N-(1-ethylbutyl) aminosulfonyl, N-ethyl-N-(2-ethylbutyl)aminosulfonyl, N-ethyl-N-(1,1,2-trimethylpropyl)aminosulfonyl, N-ethyl-N-(1,2,2-trimethyl propyl)aminosulfonyl, N-ethyl-N-(1-ethyl-1-meth ylpropyl)aminosulfonyl, N-ethyl-N-(1-ethyl-2-methylpropyl)aminosulfonyl, N-propyl-N-pentylaminosulfonyl, N-butyl-N-pentylaminosulfonyl, N,N-dipentylaminosulfonyl, N-propyl-N-hexylaminosulfonyl, N-butyl-N-hexylaminosulfonyl, N-pentyl-N-hexylaminosulfonyl or N,N-dihexylaminosulfonyl; di-(C 1 –C 4 -alkyl)amino and the dialkylamino radicals of: di-(C 1 –C 4 -alkyl)amino-C 1 –C 4 -alkoxycarbonyl and N-(di-C 1 –C 4 -alkylamino)imino-C 1 –C 6 -alkyl for example N,N-dimethylamino, N,N-diethylamino, N,N-dipropylamino, N,N-di-(1-methylethyl)amino, N,N-dibutylamino, N,N-di-(1-methylpropyl)amino, N,N-di-(2-methylpropyl)amino, N,N-di-(1,1-dimethylethyl)amino, N-ethyl-N-methylamino, N-methyl-N-propylamino, N-methyl-N-(1-methylethyl)amino, N-butyl-N-methylamino, N-methyl-N-(1-methylpropyl)amino, N-methyl-N-(2-methylpropyl)amino, N-(1,1-dimethylethyl)-N-methylamino, N-ethyl-N-propylamino, N-ethyl-N-(1-methylethyl)amino, N-butyl-N-ethylamino, N-ethyl-N-(1-methylpropyl)amino, N-ethyl-N-(2-methylpropyl)amino, N-ethyl-N-(1,1-dimethylethyl)amino, N-(1-methylethyl)-N-propylamino, N-butyl-N-propylamino, N-(1-methylpropyl)-N-propylamino, N-(2-methylpropyl)-N-propylamino, N-(1,1-dimethylethyl)-N-propylamino, N-butyl-N-(1-methylethyl)amino, N-(1-methylethyl)-N-(1-methylpropyl)amino, N-(1-methylethyl)-N-(2-methylpropyl)amino, N-(1,1-dimethylethyl)-N-(1-methylethyl)amino, N-butyl-N-(1-methylpropyl)amino, N-butyl-N-(2-methylpropyl)amino, N-butyl-N-(1,1-dimethylethyl)amino, N-(1-methylpropyl)-N-(2-methylpropyl)amino, N-(1,1-dimethylethyl)-N-(1-methylpropyl)amino or N-(1,1-dimethylethyl)-N-(2-methylpropyl)amino; di-(C 1 –C 6 -alkyl)amino, and the dialkylamino radicals of di-(C 1 –C 6 -alkyl)amino-imino-C 1 –C 6 -alkyl: di-(C 1 –C 4 -alkyl)amino as mentioned above, and also N,N-dipentylamino, N,N-dihexylamino, N-methyl-N-pentylamino, N-ethyl-N-pentylamino, N-methyl-N-hexylamino or N-ethyl-N-hexylamino; C 1 –C 4 -alkylcarbonyl: for example methylcarbonyl, ethylcarbonyl, propylcarbonyl, 1-methylethylcarbonyl, butylcarbonyl, 1-methylpropylcarbonyl, 2-methylpropylcarbonyl or 1,1-dimethylethylcarbonyl; C 1 –C 6 -alkylcarbonyl, and the alkylcarbonyl radicals of phenoxy-C 1 –C 6 -alkylcarbonyl, heterocyclyloxy-C 1 –C 6 -alkylcarbonyl, C 1 –C 6 -alkylcarbonylamino, C 1 –C 6 -alkylcarbonyl-C 1 –C 6 -alkyl: C 1 –C 4 -alkylcarbonyl, as mentioned above, and also, for example, pentylcarbonyl, 1-methylbutylcarbonyl, 2-methylbutylcarbonyl, 3-methylbutylcarbonyl, 2,2-dimethylpropylcarbonyl, 1-ethylpropylcarbonyl, hexylcarbonyl, 1,1-dimethylpropylcarbonyl, 1,2-dimethylpropylcarbonyl, 1-methylpentylcarbonyl, 2-methylpentylcarbonyl, 3-methylpentylcarbonyl, 4-methylpentylcarbonyl, 1,1-dimethylbutylcarbonyl, 1,2-dimethylbutylcarbonyl, 1,3-dimethylbutylcarbonyl, 2,2-dimethylbutylcarbonyl, 2,3-dimethylbutylcarbonyl, 3,3-dimethylbutylcarbonyl, 1-ethylbutylcarbonyl, 2-ethylbutylcarbonyl, 1,1,2-trimethylpropylcarbonyl, 1,2,2-trimethylpropylcarbonyl, l-ethyl-1-methylpropylcarbonyl or 1-ethyl-2-methylpropylcarbonyl; C 1 –C 20 -alkylcarbonyl: C 1 –C 6 -alkylcarbonyl, as mentioned above, and also heptylcarbonyl, octylcarbonyl, pentadecylcarbonyl or heptadecylcarbonyl; C 1 –C 6 -haloalkylcarbonyl: a C 1 –C 6 -alkylcarbonyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, chloroacetyl, dichloroacetyl, trichloroacetyl, fluoroacetyl, difluoroacetyl, trifluoroacetyl, chlorofluoroacetyl, dichlorofluoroacetyl, chlorodifluoroacetyl, 2-fluoroethylcarbonyl, 2-chloroethylcarbonyl, 2-bromoethylcarbonyl, 2-iodoethylcarbonyl, 2,2-difluoroethylcarbonyl, 2,2,2-trifluoroethylcarbonyl, 2-chloro-2-fluoroethylcarbonyl, 2-chloro-2,2-fluoroethylcarbonyl, 2,2-dichloro-2-fluoroethylcarbonyl, 2,2,2-trichloroethylcarbonyl, pentafluoroethylcarbonyl, 2-fluoropropylcarbonyl, 3-fluoropropylcarbonyl, 2,2-difluoropropylcarbonyl, 2,3-difluoropropylcarbonyl, 2-chloropropylcarbonyl, 3-chloropropylcarbonyl, 2,3-dichloropropylcarbonyl, 2-bromopropylcarbonyl, 3-bromopropylcarbonyl, 3,3,3-trifluoropropylcarbonyl, 3,3,3-trichloropropylcarbonyl, 2,2,3,3,3-pentafluoropropylcarbonyl, heptafluoropropylcarbonyl, 1-(fluoromethyl)-2-fluoroethylcarbonyl, 1-(chloromethyl)-2-chloroethylcarbonyl, 1-(bromomethyl)-2-bromoethylcarbonyl, 4-fluorobutylcarbonyl, 4-chlorobutylcarbonyl, 4-bromobutylcarbonyl, nonafluorobutylcarbonyl, 5-fluoropentylcarbonyl, 5-chloropentylcarbonyl, 5-bromopentylcarbonyl, Perfluoropentylcarbonyl, 6-fluorohexylcarbonyl, 6-chlorohexylcarbonyl, 6-bromohexylcarbonyl or Perfluorohexylcarbonyl; C 1 –C 4 -alkoxycarbonyl, and the alkoxycarbonyl moieties of di-(C 1 –C 4 -alkyl)amino-C 1 –C 4 -alkoxycarbonyl, for example methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, 1-methylethoxycarbonyl, butoxycarbonyl, 1-methylpropoxycarbonyl, 2-methylpropoxycarbonyl or 1,1-dimethylethoxycarbonyl; (C 1 –C 6 -alkoxy)carbonyl, and the alkoxycarbonyl moieties of C 1 –C 6 -alkoxycarbonyloxy: (C 1 –C 4 -alkoxy)carbonyl, as mentioned above, and also, for example, pentoxycarbonyl, 1-methylbutoxycarbonyl, 2-methylbutoxycarbonyl, 3-methylbutoxycarbonyl, 2,2-dimethylpropoxycarbonyl, 1-ethylpropoxycarbonyl, hexoxycarbonyl, 1,1-dimethylpropoxycarbonyl, 1,2-dimethylpropoxycarbonyl, 1-methylpentoxycarbonyl, 2-methylpentoxycarbonyl, 3-methylpentoxycarbonyl, 4-methylpentoxycarbonyl, 1,1-dimethylbutoxycarbonyl, 1,2-dimethylbutoxycarbonyl, 1,3-dimethylbutoxycarbonyl, 2,2-dimethylbutoxycarbonyl, 2,3-dimethylbutoxycarbonyl, 3,3-dimethylbutoxycarbonyl, 1-ethylbutoxycarbonyl, 2-ethylbutoxycarbonyl, 1,1,2-trimethylpropoxycarbonyl, 1,2,2-trimethylpropoxycarbonyl, 1-ethyl-1-methylpropoxycarbonyl or 1-ethyl-2-methylpropoxycarbonyl; C 1 –C 6 -haloalkoxycarbonyl: a C 1 –C 6 -alkoxycarbonyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, fluoromethoxycarbonyl, difluoromethoxycarbonyl, trifluoromethoxycarbonyl, chlorodifluoromethoxycarbonyl, bromodifluoromethoxycarbonyl, 2-fluoroethoxycarbonyl, 2-chloroethoxycarbonyl, 2-bromoethoxycarbonyl, 2-iodoethoxycarbonyl, 2,2-difluoroethoxycarbonyl, 2,2,2-trifluoroethoxycarbonyl, 2-chloro-2-fluoroethoxycarbonyl, 2-chloro-2,2-difluoroethoxycarbonyl, 2,2-dichloro-2-fluoroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, pentafluoroethoxycarbonyl, 2-fluoropropoxycarbonyl, 3-fluoropropoxycarbonyl, 2-chloropropoxycarbonyl, 3-chloropropoxycarbonyl, 2-bromopropoxycarbonyl, 3-bromopropoxycarbonyl, 2,2-difluoropropoxycarbonyl, 2,3-difluoropropoxycarbonyl, 2,3-dichloropropoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 3,3,3-trichloropropoxycarbonyl, 2,2,3,3,3-pentafluoropropoxycarbonyl, heptafluoropropoxycarbonyl, 1-(fluoromethyl)-2-fluoroethoxycarbonyl, 1-(chloromethyl)-2-chloroethoxycarbonyl, 1-(bromomethyl)-2-bromethoxycarbonyl, 4-fluorobutoxycarbonyl, 4-chlorobutoxycarbonyl, 4-bromobutoxycarbonyl, 4-iodobutoxycarbonyl, 5-fluoropentoxycarbonyl, 5-chloropentoxycarbonyl, 5-bromopentoxycarbonyl, 6-fluorohexoxycarbonyl, 6-chlorohexoxycarbonyl or 6-bromohexoxycarbonyl; (C 1 –C 4 -alkyl)carbonyloxy: acetyloxy, ethylcarbonyloxy, propylcarbonyloxy, 1-methylethylcarbonyloxy, butylcarbonyloxy, 1-methylpropylcarbonyloxy, 2-methylpropylcarbonyloxy or 1,1-dimethylethylcarbonyloxy; (C 1 –C 4 -alkylamino)carbonyl: for example methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, 1-methylethylaminocarbonyl, butylaminocarbonyl, 1-methylpropylaminocarbonyl, 2-methylpropylaminocarbonyl or 1,1-dimethylethylaminocarbonyl; (C 1 –C 6 -alkylamino)carbonyl: (C 1 –C 4 -alkylamino)carbonyl, as mentioned above, and also, for example, pentylaminocarbonyl, 1-methylbutylaminocarbonyl, 2-methylbutylaminocarbonyl, 3-methylbutylaminocarbonyl, 2,2-dimethylpropylaminocarbonyl, 1-ethylpropylaminocarbonyl, hexylaminocarbonyl, 1,1-dimethylpropylaminocarbonyl, 1,2-dimethylpropylaminocarbonyl, 1-methylpentylaminocarbonyl, 2-methylpentylaminocarbonyl, 3-methylpentylaminocarbonyl, 4-methylpentylaminocarbonyl, 1,1-dimethylbutylaminocarbonyl, 1,2-dimethylbutylaminocarbonyl, 1,3-dimethylbutylaminocarbonyl, 2,2-dimethylbutylaminocarbonyl, 2,3-dimethylbutylaminocarbonyl, 3,3-dimethylbutylaminocarbonyl, 1-ethylbutylaminocarbonyl, 2-ethylbutylaminocarbonyl, 1,1,2-trimethylpropylaminocarbonyl, 1,2,2-trimethylpropylaminocarbonyl, 1-ethyl-1-methylpropylaminocarbonyl or 1-ethyl-2-methylpropylaminocarbonyl; di-(C 1 –C 4 -alkyl)aminocarbonyl: for example N,N-dimethylaminocarbonyl, N,N-diethylaminocarbonyl, N,N-di-(1-methylethyl)aminocarbonyl, N,N-dipropylaminocarbonyl, N,N-dibutylaminocarbonyl, N,N-di-(1-methylpropyl)aminocarbonyl, N,N-di-(2-methylpropyl)aminocarbonyl, N,N-di-(1,1-dimethylethyl)aminocarbonyl, N-ethyl-N-methylaminocarbonyl, N-methyl-N-propylaminocarbonyl, N-methyl-N-(1-methylethyl)aminocarbonyl, N-butyl-N-methylaminocarbonyl, N-methyl-N-(1-methylpropyl)aminocarbonyl, N-methyl-N-(2-methylpropyl)aminocarbonyl, N-(1,1-dimethylethyl)-N-methylaminocarbonyl, N-ethyl-N-propylaminocarbonyl, N-ethyl-N-(1-methylethyl)aminocarbonyl, N-butyl-N-ethylaminocarbonyl, N-ethyl-N-(1-methylpropyl)aminocarbonyl, N-ethyl-N-(2-methylpropyl)aminocarbonyl, N-ethyl-N-(1,1-dimethylethyl)aminocarbonyl, N-(1-methylethyl)-N-propylaminocarbonyl, N-butyl-N-propylaminocarbonyl, N-(1-methylpropyl)-N-propylaminocarbonyl, N-(2-methylpropyl)-N-propylaminocarbonyl, N-(1,1-dimethylethyl)-N-propylaminocarbonyl, N-butyl-N-(1-methylethyl)aminocarbonyl, N-(1-methylethyl)-N-(1-methylpropyl)aminocarbonyl, N-(1-methylethyl)-N-(2-methylpropyl)aminocarbonyl, N-(1,1-dimethylethyl)-N-(1-methylethyl)aminocarbonyl, N-butyl-N-(1-methylpropyl) aminocarbonyl, N-butyl-N-(2-methylpropyl)aminocarbonyl, N-butyl-N-(1,1-dimethylethyl)aminocarbonyl, N-(1-methylpropyl)-N-(2-methylpropyl)aminocarbonyl, N-(1,1-dimethylethyl)-N-(1-methylpropyl)aminocarbonyl or N-(1,1-dimethylethyl)-N-(2-methylpropyl)aminocarbonyl; di-(C 1 –C 6 -alkyl)aminocarbonyl: di-(C 1 –C 4 -alkyl)aminocarbonyl as mentioned above, and also, for example, N-methyl-N-pentylaminocarbonyl, N-methyl-N-(1-methylbutyl)aminocarbonyl, N-methyl-N-(2-methylbutyl)aminocarbonyl, N-methyl-N-(3-methylbutyl)aminocarbonyl, N-methyl-N-(2,2-dimethylpropyl)aminocarbonyl, N-methyl-N-(1-ethylpropyl)aminocarbonyl, N-methyl-N-hexylaminocarbonyl, N-methyl-N-(1,1-dimethylpropyl)aminocarbonyl, N-methyl-N-(1,2-dimethylpropyl)aminocarbonyl, N-methyl-N-(1-methylpentyl)aminocarbonyl, N-methyl-N-(2-methylpentyl)aminocarbonyl, N-methyl-N-(3-methylpentyl)aminocarbonyl, N-methyl-N-(4-methylpentyl)aminocarbonyl, N-methyl-N-(1,1-dimethylbutyl)aminocarbonyl, N-methyl-N-(1,2-dimethylbutyl)aminocarbonyl, N-methyl-N-(1,3-dimethylbutyl)aminocarbonyl, N-methyl-N-(2,2-dimethylbutyl)aminocarbonyl, N-methyl-N-(2,3-dimethylbutyl)aminocarbonyl, N-methyl-N-(3,3-dimethylbutyl)aminocarbonyl, N-methyl-N-(1-ethylbutyl)aminocarbonyl, N-methyl-N-(2-ethylbutyl)aminocarbonyl, N-methyl-N-(1,1,2-trimethylpropyl)aminocarbonyl, N-methyl-N-(1,2,2-trimethylpropyl)aminocarbonyl, N-methyl-N-(1-ethyl-1-methylpropyl)aminocarbonyl, N-methyl-N-(1-ethyl-2-methylpropyl)aminocarbonyl, N-ethyl-N-pentylaminocarbonyl, N-ethyl-N-(1-methylbutyl)aminocarbonyl, N-ethyl-N-(2-methylbutyl)aminocarbonyl, N-ethyl-N-(3-methylbutyl)aminocarbonyl, N-ethyl-N-(2,2-dimethylpropyl)aminocarbonyl, N-ethyl-N-(1-ethylpropyl)aminocarbonyl, N-ethyl-N-hexylaminocarbonyl, N-ethyl-N-(1,1-dimethylpropyl)aminocarbonyl, N-ethyl-N-(1,2-dimethylpropyl)aminocarbonyl, N-ethyl-N-(1-methylpentyl)aminocarbonyl, N-ethyl-N-(2-methylpentyl)aminocarbonyl, N-ethyl-N-(3-methylpentyl)aminocarbonyl, N-ethyl-N-(4-methylpentyl)aminocarbonyl, N-ethyl-N-(1,1-dimethylbutyl)aminocarbonyl, N-ethyl-N-(1,2-dimethylbutyl)aminocarbonyl, N-ethyl-N-(1,3-dimethylbutyl)aminocarbonyl, N-ethyl-N-(2,2-dimethylbutyl)aminocarbonyl, N-ethyl-N-(2,3-dimethylbutyl)aminocarbonyl, N-ethyl-N-(3,3-dimethylbutyl)aminocarbonyl, N-ethyl-N-(1-ethylbutyl)aminocarbonyl, N-ethyl-N-(2-ethylbutyl)aminocarbonyl, N-ethyl-N-(1,1,2-trimethylpropyl)aminocarbonyl, N-ethyl-N-(1,2,2-trimethylpropyl)aminocarbonyl, N-ethyl-N-(1-ethyl-1-methylpropyl)aminocarbonyl, N-ethyl-N-(1-ethyl-2-methylpropyl)aminocarbonyl, N-Propyl-N-pentylaminocarbonyl, N-butyl-N-pentylaminocarbonyl, N,N-dipentylaminocarbonyl, N-Propyl-N-hexylaminocarbonyl, N-butyl-N-hexylaminocarbonyl, N-pentyl-N-hexylaminocarbonyl or N,N-dihexylaminocarbonyl; di-(C 1 –C 6 -alkyl)aminothiocarbonyl: for example N,N-dimethylaminothiocarbonyl, N,N-diethylaminothiocarbonyl, N,N-di-(1-methylethyl)aminothiocarbonyl, N,N-dipropylaminothiocarbonyl, N,N-dibutylaminothiocarbonyl, N,N-di-(1-methylpropyl)aminothiocarbonyl, N,N-di-(2-methylpropyl)aminothiocarbonyl, N, N-di-(1,1-dimethylethyl)aminothiocarbonyl, N-ethyl-N-methylaminothiocarbonyl, N-methyl-N-propylaminothiocarbonyl, N-methyl-N-(1,1-methylethyl)aminothiocarbonyl, N-butyl-N-methylaminothiocarbonyl, N-methyl-N-(1-methyipropyl)aminothiocarbonyl, N-methyl-N-(2-methyipropyl)aminothiocarbonyl, N-(1,1-dimethylethyl)-N-methylaminothiocarbonyl, N-ethyl-N-propylaminothiocarbonyl, N-ethyl-N-(1-methylethyl)aminothiocarbonyl, N-butyl-N-ethylaminothiocarbonyl, N-ethyl-N-(1-methylpropyl)aminothiocarbonyl, N-ethyl-N-(2-ethylpropyl)-aminothiocarbonyl, N-ethyl-N-(1,1-dimethylethyl)-aminothiocarbonyl, N-(1,1-methylethyl) N-propylaminothiocarbonyl, N-butyl-N-propylaminothiocarbonyl, N-(1-methylpropyl)-N-propylaminothiocarbonyl, N-(2-methylpropyl)-N-propylaminothiocarbonyl, N-(1,1-dimethylethyl)-N-propylaminothiocarbonyl, N-butyl-N-(1,1-methylethyl)aminothiocarbonyl, N-(1-methylethyl)-N-(1-methylpropyl)aminothiocarbonyl, N-(1-methylethyl)-N-(2-methylpropyl) aminothiocarbonyl, N-(1,1-dimethylethyl)-N-(1-methylethyl)aminothiocarbonyl, N-butyl-N-(1-methylpropyl) aminothiocarbonyl, N-butyl-N-(2-methylpropyl)aminothiocarbonyl, N-butyl-N-(1,1-dimethylethyl)aminothiocarbonyl, N-(1-methylpropyl)-N-(2-methylpropyl)aminothiocarbonyl, N-(1,1-dimethylethyl)-N-(1-methylpropyl)aminothiocarbonyl, N-(1,1-dimethylethyl)-N-(2-methylpropyl)aminothiocarbonyl, N-methyl-N-pentylaminothiocarbonyl, N-methyl-N-(1-methylbutyl)aminothiocarbonyl, N-methyl-N-(2-methylbutyl) aminothiocarbonyl, N-methyl-N-(3-methylbutyl)aminothiocarbonyl, N-methyl-N-(2,2-dimethylpropyl)aminothiocarbonyl, N-methyl-N-(1-ethylpropyl)aminothiocarbonyl, N-methyl-N-hexylaminothiocarbonyl, N-methyl-N-(1,1-dimethyipropyl) aminothiocarbonyl, N-methyl-N-(1,2-dimethylpropyl)aminothiocarbonyl, N-methyl-N-(1-methylpentyl) aminothiocarbonyl, N-methyl-N-(2-methylpentyl)aminothiocarbonyl, N-methyl-N-(3-methylpentyl)aminothiocarbonyl, N-methyl-N-(4-methylpentyl)aminothiocarbonyl, N-methyl-N-(1,1-dimethylbutyl)aminothiocarbonyl, N-methyl-N-(1,2-dimethylbutyl)aminothiocarbonyl, N-methyl-N-(1,3-dimethylbutyl)aminothiocarbonyl, N-methyl-N-(2,2-dimethylbutyl)aminothiocarbonyl, N-methyl-N-(2,3-dimethylbutyl) aminothiocarbonyl, N-methyl-N-(3,3-dimethylbutyl)aminothiocarbonyl, N-methyl-N-(1-ethylbutyl)aminothiocarbonyl, N-methyl-N-(2-ethylbutyl)aminothiocarbonyl, N-methyl-N-ethyl-N-(1,1,2-trimethylpropyl)aminothiocarbonyl, N-methyl-N-(1,2,2-trimethylpropyl)aminothiocarbonyl, N-methyl-N-(1-ethyl-1-methylpropyl)aminothiocarbonyl, N-methyl-N-(1-ethyl-2-methylpropyl)aminothiocarbonyl, N-ethyl-N-pentylaminothiocarbonyl, N-ethyl-N-(1-methylbutyl)aminothiocarbonyl, N-ethyl-N-(2-methylbutyl)aminothiocarbonyl, N-ethyl-N-(3-methylbutyl)aminothiocarbonyl, N-ethyl-N-(2,2-dimethylpropyl)aminothiocarbonyl, N-ethyl-N-(1-ethylpropyl)aminothiocarbonyl, N-ethyl-N-hexylaminothiocarbonyl, N-ethyl-N-(1,1-dimethylpropyl)aminothiocarbonyl, N-ethyl-N-(1,2-dimethylpropyl)aminothiocarbonyl, N-ethyl-N-(1-methylpentyl)aminothiocarbonyl, N-ethyl-N-(2-methylpentyl)aminothiocarbonyl, N-ethyl-N-(3-methylpentyl)aminothiocarbonyl, N-ethyl-N-(4-methylpentyl)aminothiocarbonyl, N-ethyl-N-(1,1-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(1,2-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(1,3-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(2,2-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(2,3-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(3,3-dimethylbutyl)aminothiocarbonyl, N-ethyl-N-(1-ethylbutyl)aminothiocarbonyl, N-ethyl-N-(2-ethylbutyl)aminothiocarbonyl, N-ethyl-N-(1,1,2-trimethylpropyl)aminothiocarbonyl, N-ethyl-N-(1,2,2-trimethylpropyl)aminothiocarbonyl, N-ethyl-N-(1-ethyl-1-methylpropyl)aminothiocarbonyl, N-ethyl-N-(1-ethyl-2-methylpropyl)aminothiocarbonyl, N-Propyl-N-pentylaminothiocarbonyl, N-butyl-N-pentylaminothiocarbonyl, N,N-dipentylaminothiocarbonyl, N-Propyl-N-hexylaminothiocarbonyl, N-butyl-N-hexylaminothiocarbonyl, N-pentyl-N-hexylaminothiocarbonyl or N,N-dihexylaminothiocarbonyl; C 1 –C 4 -alkoxy-C 1 –C 4 -alkyl: C 1 –C 4 -alkyl which is substituted by C 1 –C 4 -alkoxy as mentioned above, i.e., for example, methoxymethyl, ethoxymethyl, propoxymethyl, (1-methylethoxy)methyl, butoxymethyl, (1-methylpropoxy)methyl, (2-methylpropoxy)methyl, (1,1-dimethylethoxy)methyl, 2-(methoxy)ethyl, 2-(ethoxy)ethyl, 2-(propoxy)ethyl, 2-(1-methylethoxy)ethyl, 2-(butoxy)ethyl, 2-(1-methylpropoxy)ethyl, 2-(2-methylpropoxy)ethyl, 2-(1,1-dimethylethoxy)ethyl, 2-(methoxy)-propyl, 2-(ethoxy)propyl, 2-(propoxy)propyl, 2-(1-methylethoxy)propyl, 2-(butoxy)propyl, 2-(1-methylpropoxy)propyl, 2-(2-methylpropoxy)propyl, 2-(1,1-dimethylethoxy)propyl, 3-(methoxy)propyl, 3-(ethoxy)propyl, 3-(propoxy)propyl, 3-(1-methylethoxy)propyl, 3-(butoxy)propyl, 3-(1-methylpropoxy)propyl, 3-(2-methylpropoxy)propyl, 3-(1,1-dimethylethoxy)propyl, 2-(methoxy)butyl, 2-(ethoxy)butyl, 2-(propoxy)butyl, 2-(1-methylethoxy)butyl, 2-(butoxy)butyl, 2-(1-methylpropoxy)butyl, 2-(2-methylpropoxy)butyl, 2-(1,1-dimethylethoxy)butyl, 3-(methoxy)butyl, 3-(ethoxy)butyl, 3-(propoxy)butyl, 3-(1-methylethoxy)butyl, 3-(butoxy)butyl, 3-(1-methylpropoxy)butyl, 3-(2-methylpropoxy)butyl, 3-(1,1-dimethylethoxy)butyl, 4-(methoxy)butyl, 4-(ethoxy)butyl, 4-(propoxy)butyl, 4-(1-methylethoxy)butyl, 4-(butoxy)butyl, 4-(1-methylpropoxy)butyl, 4-(2-methylpropoxy)butyl or 4-(1,1-dimethylethoxy)butyl; C 1 –C 4 -alkoxy-C 1 –C 4 -alkoxy, and the alkoxyalkoxy moieties of C 1 –C 4 -alkoxy-C 1 –C 4 -alkoxycarbonyl: C 1 –C 4 -alkoxy which is substituted by C 1 –C 4 -alkoxy as mentioned above, i.e., for example, methoxymethoxy, ethoxymethoxy, propoxymethoxy, (1-methylethoxy)methoxy, butoxymethoxy, (1-methylpropoxy)methoxy, (2-methylpropoxy)methoxy, (1,1-dimethylethoxy)methoxy, 2-(methoxy)ethoxy, 2-(ethoxy)ethoxy, 2-(propoxy)ethoxy, 2-(1-methylethoxy)ethoxy, 2-(butoxy)ethoxy, 2-(1-methylpropoxy)ethoxy, 2-(2-methylpropoxy)ethoxy, 2-(1,1-dimethylethoxy)ethoxy, 2-(methoxy)propoxy, 2-(ethoxy)propoxy, 2-(propoxy)propoxy, 2-(1-methylethoxy)propoxy, 2-(butoxy)propoxy, 2-(1-methylpropoxy)propoxy, 2-(2-methylpropoxy)propoxy, 2-(1,1-dimethylethoxy)propoxy, 3-(methoxy)propoxy, 3-(ethoxy)propoxy, 3-(propoxy)propoxy, 3-(1-methylethoxy)propoxy, 3-(butoxy)propoxy, 3-(1-methylpropoxy)propoxy, 3-(2-methylpropoxy)propoxy, 3-(1,1-dimethylethoxy)propoxy, 2-(methoxy)butoxy, 2-(ethoxy)butoxy, 2-(propoxy)butoxy, 2-(1-methylethoxy)butoxy, 2-(butoxy)butoxy, 2-(1-methylpropoxy)butoxy, 2-(2-methylpropoxy)butoxy, 2-(1,1-dimethylethoxy)butoxy, 3-(methoxy)butoxy, 3-(ethoxy)butoxy, 3-(propoxy)butoxy, 3-(1-methylethoxy)butoxy, 3-(butoxy)butoxy, 3-(1-methylpropoxy)butoxy, 3-(2-methylpropoxy)butoxy, 3-(1,1-dimethylethoxy)butoxy, 4-(methoxy)butoxy, 4-(ethoxy)butoxy, 4-(propoxy)butoxy, 4-(1-methylethoxy)butoxy, 4-(butoxy)butoxy, 4-(1-methylpropoxy)butoxy, 4-(2-methylpropoxy)butoxy or 4-(1,1-dimethylethoxy)butoxy; C 3 –C 6 -alkenyl, and the alkenyl moieties of C 3 –C 6 -alkenylcarbonyl, C 3 –C 6 -alkenyloxy, C 3 –C 6 -alkenyloxycarbonyl, C 3 –C 6 -alkenylaminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 alkyl) aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkoxy)aminocarbonyl: for example prop-2-en-1-yl, but-1-en-4-yl, 1-methyl-prop-2-en-1-yl, 2-methylprop-2-en-1-yl, 2-buten-1-yl, 1-penten-3-yl, 1-penten-4-yl, 2-penten-4-yl, 1-methylbut-2-en-1-yl, 2-methylbut-2-en-1-yl, 3-methylbut-2-en-1-yl, 1-methylbut-3-en-1-yl, 2-methylbut-3-en-1-yl, 3-methylbut-3-en-1-yl, 1,1-dimethylprop-2-en-1-yl, 1,2-dimethylprop-2-en-1-yl, 1-ethylprop-2-en-1-yl, hex-3-en-1-yl, hex-4-en-1-yl, hex-5-en-1-yl, 1-methylpent-3-en-1-yl, 2-methylpent-3-en-1-yl, 3-ethylpent-3-en-1-yl, 4-ethylpent-3-en-1-yl, 1-methylpent-4-en-1-yl, 2-methylpent-4-en-1-yl, 3-methylpent-4-en-1-yl, 4-methylpent-4-en-1-yl, 1,1-dimethylbut-2-en-1-yl, 1,1-dimethylbut-3-en-1-yl, 1,2-dimethylbut-2-en-1-yl, 1,2-dimethylbut-3-en-1-yl, 1,3-dimethylbut-2-en-1-yl, 1,3-dimethylbut-3-en-1-yl, 2,2-dimethylbut-3-en-1-yl, 2,3-dimethylbut-2-en-1-yl, 2,3-dimethylbut-3-en-1-yl, 3,3-dimethylbut-2-en-1-yl, 2,3-ethylbut-2-en-1-yl, 1-ethylbut-3-en-1-yl, 2-ethylbut-2-en-1-yl, 2-ethylbut-3-en-1-yl, 1,1,2-trimethylprop-2-en-1-yl, 1-ethyl-1-methylprop-2-en-1-yl or 1-ethyl-2-methylprop-2-en-1-yl; C 2 –C 6 -alkenyl, and the alkenyl moieties of C 2 –C 6 -alkenylcarbonyl, phenyl-C 2 –C 6 -alkenylcarbonyl and heterocyclyl-C 2 –C 6 -alkenylcarbonyl: C 3 –C 6 -alkenyl as mentioned above, and also ethenyl; C 3 –C 6 -haloalkenyl: a C 3 –C 6 -alkenyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and/or iodine, i.e., for example, 2-chloroallyl, 3-chloroallyl, 2,3-dichloroallyl, 3,3-dichloroallyl, 2,3,3-trichloroallyl, 2,3-dichlorobut-2-enyl, 2-bromoallyl, 3-bromoallyl, 2,3-dibromoallyl, 3,3-dibromoallyl, 2,3,3-tribromoallyl or 2,3-dibromobut-2-enyl; C 3 –C 6 -alkynyl, and the alkyinyl moieties of C 3 –C 6 -alkynylcarbonyl, C 3 –C 6 -alkynyloxy, C 3 –C 6 -alkynyloxycarbonyl, C 3 –C 6 -alkynylaminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkoxyaminocarbonyl: for example propargyl, but-1-yn-3-yl, but-1-yn-4-yl, but-2-yn-1-yl, pent-1-yn-3-yl, pent-1-yn-4-yl, pent-1-yn-5-yl, pent-2-yn-1-yl, pent-2-yn-4-yl, pent-2-yn-5-yl, 3-methyl-but-1-yn-3-yl, 3-methylbut-1-yn-4-yl, hex-1-yn-3-yl, hex-1-yn-4-yl, hex-1-yn-5-yl, hex-1-yn-6-yl, hex-2-yn-1-yl, hex-2-yn-4-yl, hex-2-yn-5-yl, hex-2-yn-6-yl, hex-3-yn-1-yl, hex-3-yn-2-yl, 3-methylpent-1-yn-3-yl, 3-methylpent-1-yn-4-yl, 3-methylpent-1-yn-5-yl, 4-methylpent-2-yn-4-yl or 4-methylpent-2-yn-5-yl; C 2 –C 6 -alkynyl, and the alkynyl moieties of C 2 –C 6 alkynylcarbonyl: C 3 –C 6 -alkynyl as mentioned above, and also ethynyl; C 3 –C 6 -haloalkynyl: a C 3 –C 6 -alkynyl radical as mentioned above which is partially or fully substitued by fluorine, chlorine, bromine and/or iodine, i.e., for example, 1,1-difluoroprop-2-yn-1-yl, 3-iodoprop-2-yn-1-yl, 4-fluorobut-2-yn-1-yl, 4-chlorobut-2-yn-1-yl, 1,1-difluorobut-2-yn-1-yl, 4-iodobut-3-yn-1-yl, 5-fluoropent-3-yn-1-yl, 5-iodopent-4-yn-1-yl, 6-fluorohex-4-yn-1-yl or 6-iodohex-5-yn-1-yl; C 3 –C 6 -cycloalkyl, and the cycloalkyl moieties of C 3 –C 6 -cycloalkylcarbonyl: for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl; heterocyclyl, and the heterocyclyl moieties of heterocyclylcarbonyl, heterocyclyl-C 1 –C 6 -alkyl, heterocyclyloxy, heterocyclylthio, heterocyclyloxyalkylcarbonyl, heterocyclyloxycarbonyl, heterocyclyloxythiocarbonyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkyl)-N-(heterocyclyl)aminocarbonyl, heterocyclylaminocarbonyl: a saturated, partially saturated or unsaturated 5- or 6-membered heterocyclic ring which is attached via a carbon and has one to four identical or different hetero atoms selected from the following group: oxygen, sulfur or nitrogen, i.e., for example, 5-membered rings having a hetero atom such as, for example: tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, tetrahydropyrrol-2-yl, tetrahydropyrrol-3-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 4,5-dihydrofuran-2-yl, 4,5-dihydrofuran-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,5-dihydrothien-2-yl, 2,5-dihydrothien-3-yl, 4,5-dihydrothien-2-yl, 4,5-dihydrothien-3-yl, 2,3-dihydro-1H-pyrrol-2-yl, 2,3-dihydro-1H-pyrrol-3-yl, 2,5-dihydro-1H-pyrrol-2-yl, 2,5-dihydro-1H-pyrrol-3-yl, 4,5-dihydro-1H-pyrrol-2-yl, 4,5-dihydro-1H-pyrrol-3-yl, 3,4-dihydro-2H-pyrrol-2-yl, 3,4-dihydro-2H-pyrrol-3-yl, 3,4-dihydro-5H-pyrrol-2-yl, 3,4-dihydro-5H-pyrrol-3-yl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, pyrrol-2-yl or pyrrol-3-yl;

›5-membered rings having two hetero atoms such as…

5-membered rings having two hetero atoms such as, for example,

tetrahydropyrazol-3-yl, tetrahydropyrazol-3-yl, tetrahydropyrazol-4-yl, tetrahydroisoxazol-3-yl, tetrahydroisoxazol-4-yl, tetrahydroisoxazol-5-yl, 1,2-oxathiolan-3-yl, 1,2-oxathiolan-4-yl, 1,2-oxathiolan-5-yl, tetrahydroisothiazol-3-yl, tetrahydroisothiazol-4-yl, tetrahydroisothiazol-5-yl, 1,2-dithiolan-3-yl, 1,2-dithiolan-4-yl, tetrahydroimidazol-2-yl, tetrahydroimidazol-4-yl, tetrahydrooxazol-2-yl, tetrahydrooxazol-4-yl, tetrahydrooxazol-5-yl, tetrahydrothiazol-2-yl, tetrahydrothiazol-4-yl, tetrahydrothiazol-5-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, 1,3-oxathiolan-2-yl, 1,3-oxathiolan-4-yl, 1,3-oxathiolan-5-yl, 1,3-dithiolan-2-yl, 1,3-dithiolan-4-yl, 4,5-dihydro-1H-pyrazol-3-yl, 4,5-dihydro-1H-pyrazol-4-yl, 4,5-dihydro-1H-pyrazol-5-yl, 2,5-dihydro-1H-pyrazol-3-yl, 2,5-dihydro-1H-pyrazol-4-yl, 2,5-dihydro-1H-pyrazol-5-yl, 4,5-dihydroisoxazol-3-yl, 4,5-dihydroisoxazol-4-yl, 4,5-dihydroisoxazol-5-yl, 2,5-dihydroisoxazol-3-yl, 2,5-dihydroisoxazol-4-yl, 2,5-dihydroisoxazol-5-yl, 2,3-dihydroisoxazol-3-yl, 2,3-dihydroisoxazol-4-yl, 2,3-dihydroisoxazol-5-yl, 4,5-dihydroisothiazol-3-yl, 4,5-dihydroisothiazol-4-yl, 4,5-dihydroisothiazol-5-yl, 2,5-dihydroisothiazol-3-yl, 2,5-dihydroisothiazol-4-yl, 2,5-dihydroisothiazol-5-yl, 2,3-dihydroisothiazol-3-yl, 2,3-dihydroisothiazol-4-yl, 2,3-dihydroisothiazol-5-yl, Δ 3 -1,2-dithiol-3-yl, Δ 3 -1,2-dithiol-4-yl, Δ 3 -1,2-dithiol-5-yl, 4,5-dihydro-1H-imidazol-2-yl, 4,5-dihydro-1H-imidazol-4-yl, 4,5-dihydro-1H-imidazol-5-yl, 2,5-dihydro-1H-imidazol-2-yl, 2,5-dihydro-1H-imidazol-4-yl, 2,5-dihydro-1H-imidazol-5-yl, 2,3-dihydro-1H-imidazol-2-yl, 2,3-dihydro-1H-imidazol-4-yl, 4,5-dihydrooxazol-2-yl, 4,5-dihydrooxazol-4-yl, 4,5-dihydrooxazol-5-yl, 2,5-dihydrooxazol-2-yl, 2,5-dihydrooxazol-4-yl, 2,5-dihydrooxazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 4,5-dihydrothiazol-2-yl, 4,5-dihydrothiazol-4-yl, 4,5-dihydrothiazol-5-yl, 2,5-dihydrothiazol-2-yl, 2,5-dihydrothiazol-4-yl, 2,5-dihydrothiazol-5-yl, 2,3-dihydrothiazol-2-yl, 2,3-dihydrothiazol-4-yl, 2,3-dihydrothiazol-5-yl, 1,3-dioxol-2-yl, 1,3-dioxol-4-yl, 1,3-dithiol-2-yl, 1,3-dithiol-4-yl, 1,3-oxathiol-2-yl, 1,3-oxathiol-4-yl, 1,3-oxathiol-5-yl, pyrazol-3-yl, pyrazol-4-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, imidazol-2-yl, imidazol-4-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, thiazol-2-yl, thiazol-4-yl or thiazol-5-yl;

5-membered rings having 3 hetero atoms such as, for example,

1,2,3-Δ 2 -oxadiazolin-4-yl, 1,2,3-Δ 2 -oxadiazolin-5-yl, 1,2,4-Δ 4 -oxadiazolin-3-yl, 1,2,4-Δ 4 -oxadiazolin-5-yl, 1,2,4-Δ 2 -oxadiazolin-3-yl, 1,2,4-Δ 2 -oxadiazolin-5-yl, 1,2,4-Δ 3 -oxadiazolin-3-yl, 1,2,4-Δ 3 -oxadiazolin-5-yl, 1,3,4-Δ 2 -oxadiazolin-2-yl, 1,3,4-Δ 2 -oxadiazolin-5-yl, 1,3,4-Δ 3 -oxadiazolin-2-yl, 1,3,4-oxadiazolin-2-yl, 1,2,4-Δ 4 -thiadiazolin-3-yl, 1,2,4-Δ 4 -thiadiazolin-5-yl, 1,2,4-Δ 3 -thiadiazolin-3-yl, 1,2,4-Δ 3 -thiadiazolin-5-yl, 1,2,4-Δ 2 -thiadiazolin-3-yl, 1,2,4-Δ 2 -thiadiazolin-5-yl, 1,2,4-Δ 2 -thiadiazolin-2-yl, 1,3,4-Δ 2 -thiadiazolin-5-yl, 1,3,4-Δ 3 -thiadiazolin-2-yl, 1,3,4-thiadiazolin-2-yl, 1,3,2-dioxathiolan-4-yl, 1,2,3-Δ 2 -triazolin-4-yl, 1,2,3-Δ 2 -triazolin-5-yl, 1,2,4-Δ 2 -triazolin-3-yl, 1,2,4-Δ 2 -triazolin-5-yl, 1,2,4-Δ 3 -triazolin-3-yl, 1,2,4-Δ 3 -triazolin-5-yl, 1,2,4-Δ 1 -triazolin-2-yl, 1,2,4-triazolin-3-yl, 3H-1,2,4-dithiazol-5-yl, 2H-1,3,4-dithiazol-5-yl, 2H-1,3,4-oxathiazol-5-yl, 1,2,3-oxadiazol-4-yl, 1,2,3-oxadiazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4,-oxadiazol-5-yl, 1,3,4-oxadiazol-2-yl, 1,2,3-thiadiazol-4-yl, 1,2,3-thiadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,3,4-thiadiazolyl-2-yl, 1,2,3-triazol-4-yl or 1,2,4-triazol-3-yl;

5-membered rings having 4 hetero atoms such as, for example, tetrazol-5-yl,

6-membered rings having 1 hetero atom such as, for example:

tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, tetrahydrothiopyran-2-yl, tetrahydrothiopyran-3-yl, tetrahydrothiopyran-4-yl, 2H-3,4-dihydropyran-6-yl, 2H-3,4-dihydropyran-5-yl, 2H-3,4-dihydropyran-4-yl, 2H-3,4-dihydropyran-3-yl, 2H-3,4-dihydropyran-2-yl, 2H-3,4-dihydropyran-6-yl, 2H-3,4-dihydrothiopyran-5-yl, 2H-3,4-dihydrothiopyran-4-yl, 2H-3,4-dihydropyran-3-yl, 2H-3,4-dihydropyran-2-yl, 1,2,3,4-tetrahydropyridin-6-yl, 1,2,3,4-tetrahydropyridin-5-yl, 1,2,3,4-tetrahydropyridin-4-yl, 1,2,3,4-tetrahydropyridin-3-yl, 1,2,3,4-tetrahydropyridin-2-yl, 2H-5,6-dihydropyran-2-yl, 2H-5,6-dihydropyran-3-yl, 2H-5,6-dihydropyran-4-yl, 2H-5,6-dihydropyran-5-yl, 2H-5,6-dihydropyran-6-yl, 2H-5,6-dihydropyran-5-yl, 2H-5,6-dihydrothiopyran-6-yl, 2H-5,6-dihydrothiopyran-2-yl, 2H-5,6-dihydrothiopyran-3-yl, 2H-5,6-dihydrothiopyran-4-yl, 2H-5,6-dihydrothiopyran-5-yl, 2H-5,6-dihydrothiopyran-6-yl, 1,2,5,6-tetrahydropyridin-2-yl, 1,2,5,6-tetrahydropyridin-3-yl, 1,2,5,6-tetrahydropyridin-4-yl, 1,2,5,6-tetrahydropyridin-5-yl, 1,2,5,6-tetrahydropyridin-6-yl, 2,3,4,5-tetrahydropyridin-2-yl, 2,3,4,5-tetrahydropyridin-3-yl, 2,3,4,5-tetrahydropyridin-4-yl, 2,3,4,5-tetrahydropyridin-5-yl, 2,3,4,5-tetrahydropyridin-6-yl, 4H-pyran-2-yl, 4H-pyran-3-yl, 4H-pyran-4-yl, 4H-thiopyran-2-yl, 4H-thiopyran-3-yl, 4H-thiopyran-4-yl, 1,4-dihydropyridin-2-yl, 1,4-dihydropyridin-3-yl, 1,4-dihydropyridin-4-yl, 2H-pyran-2-yl, 2H-pyran-3-yl, 2H-pyran-4-yl, 2H-pyran-5-yl, 2H-pyran-6-yl, 2H-thiopyran-2-yl, 2H-thiopyran-3-yl, 2H-thiopyran-4-yl, 2H-thiopyran-5-yl, 2H-thiopyran-6-yl, 1,2-dihydropyridin-2-yl, 1,2-dihydropyridin-3-yl, 1,2-dihydropyridin-4-yl, 1,2-dihydropyridin-5-yl, 1,2-dihydropyridin-6-yl, 3,4-dihydropyridin-2-yl, 3,4-dihydropyridin-3-yl, 3,4-dihydropyridin-4-yl, 3,4-dihydropyridin-5-yl, 3,4-dihydropyridin-6-yl, 2,5-dihydropyridin-2-yl, 2,5-dihydropyridin-3-yl, 2,5-dihydropyridin-4-yl, 2,5-dihydropyridin-5-yl, 2,5-dihydropyridin-6-yl, 2,3-dihydropyridin-2-yl, 2,3-dihydropyridin-3-yl, 2,3-dihydropyridin-4-yl, 2,3-dihydropyridin-5-yl, 2,3-dihydropyridin-6-yl, pyridin-2-yl, pyridin-3-yl or pyridin-4-yl; 6-membered rings having 2 hetero atoms such as, for example, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 1,3-dithian-2-yl, 1,3-dithian-4-yl, 1,3-dithian-5-yl, 1,4-dithian-2-yl, 1,3-oxathian-2-yl, 1,3-oxathian-4-yl, 1,3-oxathian-5-yl, 1,3-oxathian-6-yl, 1,4-oxathian-2-yl, 1,4-oxathian-3-yl, 1,2-dithian-3-yl, 1,2-dithian-4-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahydropyrimidin-5-yl, hexahydropyrazin-2-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, tetrahydro-1,3-oxazin-2-yl, tetrahydro-1,3-oxazin-4-yl, tetrahydro-1,3-oxazin-5-yl, tetrahydro-1,3-oxazin-6-yl, tetrahydro-1,3-thiazin-2-yl, tetrahydro-1,3-thiazin-4-yl, tetrahydro-1,3-thiazin-5-yl, tetrahydro-1,3-thiazin-6-yl, tetrahydro-1,4-thiazin-2-yl, tetrahydro-1,4-thiazin-3-yl, tetrahydro-1,4-oxazin-2-yl, tetrahydro-1,4-oxazin-3-yl, tetrahydro-1,2-oxazin-3-yl, tetrahydro-1,2-oxazin-4-yl, tetrahydro-1,2-oxazin-5-yl, tetrahydro-1,2-oxazin-6-yl, 2H-5,6-dihydro-1,2-oxazin-3-yl, 2H-5,6-dihydro-1,2-oxazin-4-yl, 2H-5,6-dihydro-1,2-oxazin-5-yl, 2H-5,6-dihydro-1,2-oxazin-6-yl, 2H-5,6-dihydro-1,2-thiazin-3-yl, 2H-5,6-dihydro-1,2-thiazin-4-yl, 2H-5,6-dihydro-1,2-thiazin-5-yl, 2H-5,6-dihydro-1,2-thiazin-6-yl, 4H-5,6-dihydro-1,2-oxazin-3-yl, 4H-5,6-dihydro-1,2-oxazin-4-yl, 4H-5,6-dihydro-1,2-oxazin-5-yl, 4H-5,6-dihydro-1,2-oxazin-6-yl, 4H-5,6-dihydro-1,2-thiazin-3-yl, 4H-5,6-dihydro-1,2-thiazin-4-yl, 4H-5,6-dihydro-1,2-thiazin-5-yl, 4H-5,6-dihydro-1,2-thiazin-6-yl, 2H-3,6-dihydro-1,2-oxazin-3-yl, 2H-3,6-dihydro-1,2-oxazin-4-yl, 2H-3,6-dihydro-1,2-oxazin-5-yl, 2H-3,6-dihydro-1,2-oxazin-6-yl, 2H-3,6-dihydro-1,2-thiazin-3-yl, 2H-3,6-dihydro-1,2-thiazin-4-yl, 2H-3,6-dihydro-1,2-thiazin-5-yl, 2H-3,6-dihydro-1,2-thiazin-6-yl, 2H-3,4-dihydro-1,2-oxazin-3-yl, 2H-3,4-dihydro-1,2-oxazin-4-yl, 2H-3,4-dihydro-1,2-oxazin-5-yl, 2H-3,4-dihydro-1,2-oxazin-6-yl, 2H-3,4-dihydro-1,2-thiazin-3-yl, 2H-3,4-dihydro-1,2-thiazin-4-yl, 2H-3,4-dihydro-1,2-thiazin-5-yl, 2H-3,4-dihydro-1,2-thiazin-6-yl, 2,3,4,5-tetrahydropyridazin-3-yl, 2,3,4,5-tetrahydropyridazin-4-yl, 2,3,4,5-tetrahydropyridazin-5-yl, 2,3,4,5-tetrahydropyridazin-6-yl, 3,4,5,6-tetrahydropyridazin-3-yl, 3,4,5,6-tetrahydropyridazin-4-yl, 1,2,5,6-tetrahydropyridazin-3-yl, 1,2,5,6-tetrahydropyridazin-4-yl, 1,2,5,6-tetrahydropyridazin-5-yl, 1,2,5,6-tetrahydropyridazin-6-yl, 1,2,3,6-tetrahydropyridazin-3-yl, 1,2,3,6-tetrahydropyridazin-4-yl, 4H-5,6-dihydro-1,3-oxazin-2-yl, 4H-5,6-dihydro-1,3-oxazin-4-yl, 4H-5,6-dihydro-1,3-oxazin-5-yl, 4H-5,6-dihydro-1,3-oxazin-6-yl, 4H-5,6-dihydro-1,3-thiazin-2-yl, 4H-5,6-dihydro-1,3-thiazin-4-yl, 4H-5,6-dihydro-1,3-thiazin-5-yl, 4H-5,6-dihydro-1,3-thiazin-6-yl, 3,4,5,6-tetrahydropyrimidin-2-yl, 3,4,5,6-tetrahydropyrimidin-4-yl, 3,4,5,6-tetrahydropyrimidin-5-yl, 3,4,5,6-tetrahydropyrimidin-6-yl, 1,2,3,4-tetrahydropyrazin-2-yl, 1,2,3,4-tetrahydropyrazin-5-yl, 1,2,3,4-tetrahydropyrimidin-2-yl, 1,2,3,4-tetrahydropyrimidin-4-yl, 1,2,3,4-tetrahydropyrimidin-5-yl, 1,2,3,4-tetrahydropyrimidin-6-yl, 2,3-dihydro-1,4-thiazin-2-yl, 2,3-dihydro-1,4-thiazin-3-yl, 2,3-dihydro-1,4-thiazin-5-yl, 2,3-dihydro-1,4-thiazin-6-yl, 2H-1,2-oxazin-3-yl, 2H-1,2-oxazin-4-yl, 2H-1,2-oxazin-5-yl, 2H-1,2-oxazin-6-yl, 2H-1,2-thiazin-3-yl, 2H-1,2-thiazin-4-yl, 2H-1,2-thiazin-5-yl, 2H-1,2-thiazin-6-yl, 4H-1,2-oxazin-3-yl, 4H-1,2-oxazin-4-yl, 4H-1,2-oxazin-5-yl, 4H-1,2-oxazin-6-yl, 4H-1,2-thiazin-3-yl, 4H-1,2-thiazin-4-yl, 4H-1,2-thiazin-5-yl, 4H-1,2-thiazin-6-yl, 6H-1,2-oxazin-3-yl, 6H-1,2-oxazin-4-yl, 6H-1,2-oxazin-5-yl, 6H-1,2-oxazin-6-yl, 6H-1,2-thiazin-3-yl, 6H-1,2-thiazin-4-yl, 6H-1,2-thiazin-5-yl, 6H-1,2-thiazin-6-yl, 2H-1,3-oxazin-2-yl, 2H-1,3-oxazin-4-yl, 2H-1,3-oxazin-5-yl, 2H-1,3-oxazin-6-yl, 2H-1,3-thiazin-2-yl, 2H-1,3-thiazin-4-yl, 2H-1,3-thiazin-5-yl, 2H-1,3-thiazin-6-yl, 4H-1,3-oxazin-2-yl, 4H-1,3-oxazin-4-yl, 4H-1,3-oxazin-5-yl, 4H-1,3-oxazin-6-yl, 4H-1,3-thiazin-2-yl, 4H-1,3-thiazin-4-yl, 4H-1,3-thiazin-5-yl, 4H-1,3-thiazin-6-yl, 6H-1,3-oxazin-2-yl, 6H-1,3-oxazin-4-yl, 6H-1,3-oxazin-5-yl, 6H-1,3-oxazin-6-yl, 6H-1,3-thiazin-2-yl, 6H-1,3-oxazin-4-yl, 6H-1,3-oxazin-5-yl, 6H-1,3-thiazin-6-yl, 2H-1,4-oxazin-2-yl, 2H-1,4-oxazin-3-yl, 2H-1,4-oxazin-5-yl, 2H-1,4-oxazin-6-yl, 2H-1,4-thiazin-2-yl, 2H-1,4-thiazin-3-yl, 2H-1,4-thiazin-5-yl, 2H-1,4-thiazin-6-yl, 4H-1,4-oxazin-2-yl, 4H-1,4-oxazin-3-yl, 4H-1,4-thiazin-2-yl, 4H-1,4-thiazin-3-yl, 1,4-dihydropyridazin-3-yl, 1,4-dihydropyridazin-4-yl, 1,4-dihydropyridazin-5-yl, 1,4-dihydropyridazin-6-yl, 1,4-dihydropyrazin-2-yl, 1,2-dihydropyrazin-2-yl, 1,2-dihydropyrazin-3-yl, 1,2-dihydropyrazin-5-yl, 1,2-dihydropyrazin-6-yl, 1,4-dihydropyrimidin-2-yl, 1,4-dihydropyrimidin-4-yl, 1,4-dihydropyrimidin-5-yl, 1,4-dihydropyrimidin-6-yl, 3,4-dihydropyrimidin-2-yl, 3,4-dihydropyrimidin-4-yl, 3,4-dihydropyrimidin-5-yl or 3,4-dihydropyrimidin-6-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl or pyrazin-2-yl;

›6-membered rings having 3 hetero atoms such as…

6-membered rings having 3 hetero atoms such as, for example,

1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl, 1,2,4-triazin-5-yl or 1,2,4-triazin-6-yl;

6-membered rings having 4 hetero atoms such as, for example,

1,2,4,5-tetrazin-3-yl;

where, if appropriate, the sulfur of the abovementioned heterocycles may be oxidized to S=o or S(═O) 2 ;

and where a bicyclic ring system may be formed with a fused-on phenyl ring or with a C 3 –C 6 -carbocycle or with another 5- to 6-membered heterocycle.

N-linked heterocyclyl: a saturated, partially saturated or unsaturated 5- or 6-membered heterocyclic ring which is attached via nitrogen and which contains at least one nitrogen and optionally one to three identical or different hetero atoms selected from the following group: oxygen, sulfur or nitrogen, i.e., for example,

5-membered rings having 1 hetero atom which are linked by a nitrogen, such as, for example,

tetrahydropyrrol-1-yl, 2,3-dihydro-1H-pyrrol-1-yl, 2,5-dihydro-1H-pyrrol-1-yl or pyrrol-1-yl;

5-membered rings having 2 hetero atoms which are linked by a nitrogen such as, for example,

tetrahydropyrazol-1-yl, tetrahydroisoxazol-2-yl, tetrahydroisothiazol-2-yl, tetrahydroimidazol-1-yl, tetrahydrooxazol-3-yl, tetrahydrothiazol-3-yl, 4,5-dihydro-1H-pyrazol-1-yl, 2,5-dihydro-1H-pyrazol-1-yl, 2,3-dihydro-1H-pyrazol-1-yl, 2,5-dihydroisoxazol-2-yl, 2,3-dihydroisoxazol-2-yl, 2,5-dihydroisothiazol-2-yl, 2,3-dihydroisoxazol-2-yl, 4,5-dihydro-1H-imidazol-1-yl, 2,5-dihydro-1H-imidazol-1-yl, 2,3-dihydro-1H-imidazol-1-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrothiazol-3-yl, pyrazol-1-yl or imidazol-1-yl;

5-membered rings having 3 hetero atoms which are linked by a nitrogen such as, for example,

1,2,4-Δ 4 -oxadiazolin-2-yl, 1,2,4-Δ 2 -oxadiazolin-4-yl, 1,2,4-Δ 3 -oxadiazolin-2-yl, 1,3,4-Δ 2 -oxadiazolin-4-yl, 1,2,4-Δ 2 -thiadiazolin-2-yl, 1,2,4-Δ 3 -thiadiazolin-2-yl, 1,2,4-Δ 2 -thiadiazolin-4-yl, 1,3,4-Δ 2 -thiadiazolin-4-yl, 1,2,3-Δ 2 -triazolin-1-yl, 1,2,4-Δ 2 -triazolin-1-yl, 1,2,4-Δ 2 -triazolin-4-yl, 1,2,4-Δ 3 -triazolin-1-yl, 1,2,4-Δ 1 -triazolin-4-yl, 1,2,3-triazol-1-yl or 1,2,4-triazol-1-yl;

5-membered rings having 4 hetero atoms which are linked by a nitrogen such as, for example,

tetrazol-1-yl;

and 6-membered rings having 1 hetero atom which are linked by a nitrogen, such as, for example

piperidin-1-yl, 1,2,3,4-tetrahydropyridin-1-yl, 1,2,5,6-tetrahydropyridin-1-yl, 1,4-dihydropyridin-1-yl or 1,2-dihydropyridin-1-yl;

6-membered rings having 2 hetero atoms which are linked by a nitrogen such as, for example,

hexahydropyrimidin-1-yl, hexahydropyrazin-1-yl, hexahydropyridazin-1-yl, tetrahydro-1,3-oxazin-3-yl, tetrahydro-1,3-thiazin-3-yl, tetrahydro-1,4-thiazin-4-yl, tetrahydro-1,4-oxazin-4-yl, tetrahydro-1,2-oxazin-2-yl, 2H-5,6-dihydro-1,2-oxazin-2-yl, 2H-5,6-dihydro-1,2-thiazin-2-yl, 2H-3,6-dihydro-1,2-oxazin-2-yl, 2H-3,6-dihydro-1,2-thiazin-oxazin-2-yl, 2H-3,4-dihydro-1,2-thiazin-2-yl, 2,3,4,5-tetrahydropyridazin-2-yl, 1,2,5,6-tetrahydropyridazin-1-yl, 1,2,5,6-tetrahydropyridazin-2-yl, 1,2,3,6-tetrahydropyridazin-1-yl, 3,4,5,6-tetrahydropyrimidin-3-yl, 1,2,3,4-tetrahydropyrazin-1-yl, 1,2,3,4-tetrahydropyrimidin-1-yl, 1,2,3,4-tetrahydropyrimidin-3-yl, 2,3-dihydro-1,4-thiazin-4-yl, 2H-1,2-oxazin-2-yl, 2H-1,2-thiazin-2-yl, 4H-1,4-oxazin-4-yl, 4H-1,4-thiazin-4-yl, 1,4-dihydropyridazin-1-yl, 1,4-dihydropyrazin-1-yl, 1,2-dihydropyrazin-1-yl, 1,4-dihydropyrimidin-1-yl or 3,4-dihydropyrimidin-3-yl, and also cyclic imides which are linked via nitrogen, such as:

phthalimide, tetrahydrophthalimide, succinimide, maleimide or glutarimide, and also 4-oxo-1,4-dihydropyridin-1-yl.

All phenyl rings or heterocyclyl radicals, and also all phenyl components in phenyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, phenoxy, phenylthio, phenylcarbonyl, phenylalkenylcarbonyl, phenoxycarbonyl, phenoxyalkylcarbonyl, phenylaminocarbonyl and N—(C 1 –C 6 -alkyl)-N-phenylaminocarbonyl or heterocyclyl components in heterocyclyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, heterocyclyloxy, heterocyclylthio, heterocyclylcarbonyl, heterocyclylalkenylcarbonyl, heterocyclyloxyalkylcarbonyl, heterocyclyloxycarbonyl, heterocyclylaminocarbonyl and N—(C 1 –C 6 -alkyl)-N-heterocyclylaminocarbonyl are, unless stated otherwise, preferably unsubstituted, or they carry one to three halogen atoms and/or one nitro group, one cyano radical and/or one or two methyl, trifluoromethyl, methoxy or trifluoromethoxy substituents.

The compounds of the formula I according to the invention where R 4 =IIa are referred to as compounds of the formula Ia, and compounds of the formula I where R 4 =IIb are referred to as Ib.

The compounds of the formula I should be particularly emphasized, where

R 7 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 3 –C 6 -haloalkynyl, C 3 –C 6 -Cycloalkyl, C 1 –C 20 -alkylcarbonyl, C 2 –C 6 -alkenylcarbonyl, C 2 –C 6 -alkynylcarbonyl, C 3 –C 6 -cycloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, C 3 –C 6 -alkenyloxycarbonyl, C 3 –C 6 -alkynyloxycarbonyl, C 1 –C 6 -alkylthiocarbonyl, C 1 –C 6 -alkylaminocarbonyl, C 3 –C 6 -alkenylaminocarbonyl, C 3 –C 6 -alkynylaminocarbonyl, N,N-di-(C 1 –C 6 -alkyl)-aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkoxy)aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkoxy)-aminocarbonyl, di-(C 1 –C 6 -alkyl)aminothiocarbonyl, C 1 –C 6 -alkylcarbonyl-C 1 –C 6 -alkyl, C 1 –C 6 -alkoxyimino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl or N,N-di-(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl, where the alkyl, cycloalkyl and alkoxy radicals mentioned may be partially or fully halogenated and/or may carry one to thre of the following groups:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, di-(C 1 –C 4 -alkyl)amino, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, C 1 –C 4 -alkoxy-C 1 – 4 -alkoxycarbonyl, di-(C 1 –C 4 -alkyl)amino-C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, C 1 –C 4 -alkylaminocarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, phenylcarbonyl, heterocyclylcarbonyl, phenoxycarbonyl, heterocyclyloxycarbonyl, phenoxythiocarbonyl, heterocyclyloxythiocarbonyl, phenoxy-C 1 –C 6 -alkylcarbonyl, heterocyclyloxy-C 1 –C 6 alkylcarbonyl, phenylaminocarbonyl, N—(C 1 –C 6 -alkyl)-N-(phenyl)aminocarbonyl, heterocyclylaminocarbonyl, N—(C 1 –C 6 -alkyl)-N-(heterocyclyl)aminocarbonyl, phenyl-C 2 –C 6 -alkenylcarbonyl or heterocyclyl-C 2 –C 6 -alkenylcarbonyl, where the phenyl and the heterocyclyl radical of the 20 last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

›With a view to the use of the…

With a view to the use of the compounds of the formula I according to the invention as herbicides, the variables preferably have the following meanings, in each case on their own or in combination:

R 1 is nitro, halogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfonyl or C 1 –C 6 -haloalkylsulfonyl; R 2 , R 3 are hydrogen, C 1 –C 6 -alkyl or halogen; R 4 is a compound of IIa or IIb

where

R 5 is halogen, OR 7 , SR 7 , SO 2 R 8 , OSO 2 R 8 , OPOR 8 R 9 , OPR 8 R 9 , OPSR 8 R 9 , NR 10 R 11 , ONR 11 R 1 2, N-linked heterocyclyl or O—(N-linked heterocyclyl), where the heterocyclyl radical of the two last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 6 is halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, di-(C 1 –C 6 -alkoxy)methyl, di-(C 1 –C 6 -alkylthio)methyl, (C 1 –C 6 -alkoxy)(C 1 –C 6 -alkylthio)methyl, hydroxyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkoxycarbonyloxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfonyl, C 1 –C 6 -haloalkylsulfonyl, C 1 –C 6 -alkylcarbonyl, C 1 –C 6 -haloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl or C 1 –C 6 -haloalkoxycarbonyl; or

two radicals R 6 , which are linked to the same carbon, together form an —O—(CH 2 ) m —O—, —O—(CH 2 ) m —S—, —S—(CH 2 ) m —S—, —O—(CH 2 ) n - or —S—(CH 2 ) n -chain which may be substituted by one to three radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl;

or two radicals R 6 , which are linked to the same carbon, together form a-(CH 2 ) p chain which may be interrupted by oxygen or sulfur and/or may be substituted by one to four radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl;

or two radicals R 6 , which are linked to the same carbon, together with this carbon form a carbonyl group; or two radicals R 6 , which are linked to different carbons, together form a-(CH 2 ) n chain which may be substituted by one to three radicals from the following group:

halogen, C 1 –C 6 -alkyl, C 1 –C 6 -alkoxy, hydroxyl or C 1 –C 6 -alkoxycarbonyl;

R 7 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 1 –C 20 -alkylcarbonyl, C 2 –C 6 -alkenylcarbonyl, C 3 –C 6 -cycloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, C 3 –C 6 -alkenyloxycarbonyl, C 3 –C 6 -alkynyloxycarbonyl, (C 1 –C 20 -alkylthio)carbonyl (particularly preferably (C 1 –C 6 -alkylthio)carbonyl), C 1 –C 6 -alkylaminocarbonyl, C 3 –C 6 -alkenylaminocarbonyl, C 3 –C 6 -alkynylaminocarbonyl, N,N-di-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkoxy) aminocarbonyl, N—(C 3 –C 6 -alkynyl)-N-(C 1 –C 6 -alkoxy) aminocarbonyl, di-(C 1 –C 6 -alkyl)aminothiocarbonyl, C 1 –C 6 -alkylcarbonyl-C 1 –C 6 -alkyl, C 1 –C 6 -alkoxyimino-C 1 –C 6 -alkyl, N—(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl or N,N-di-(C 1 –C 6 -alkylamino)imino-C 1 –C 6 -alkyl, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, phenylcarbonyl, heterocyclylcarbonyl, phenoxycarbonyl, heterocyclyloxycarbonyl, phenoxythiocarbonyl, heterocyclyloxythiocarbonyl, phenoxy-C 1 –C 6 -alkylcarbonyl, heterocyclyloxy-C 1 –C 6 -alkylcarbonyl, phenyl-C 2 –C 6 -alkenylcarbonyl or heterocyclyl-C 2 –C 6 -alkenylcarbonyl, where the phenyl and the heterocyclyl radical of the 16 last mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 8 , R 9 are C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -cycloalkyl, hydroxy, C 1 –C 6 -alkoxy, di-C 1 –C 6 -alkylamino, or di-(C 1 –C 6 -haloalkyl)amino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenoxy, heterocyclyloxy, where the phenyl- and the heterocyclyl radical of the last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 10 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -cycloalkyl, C 1 –C 6 -alkoxy, C 3 –C 6 -alkenyloxy or di-(C 1 –C 6 -alkyl)amino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three radicals from the following group:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl or heterocyclyl-C 1 –C 6 -alkyl, where the phenyl or heterocyclyl radical of the four last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

›R 11 , R 12 are C 1…

R 11 , R 12 are C 1 –C 6 -alkyl or C 3 –C 6 -alkenyl; l 0 to 6; m 2 to 4; n 1 to 5; p 2 to 5.

Particular preference is given to compounds of the formula I where the variables have the following meanings, either on their own or in combination:

R 1 is halogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, C 1 –C 6 -alkoxy, C 1 –C 6 -alkylthio or C 1 –C 6 -alkylsulfonyl; in particular halogen, such as fluorine or chlorine, C 1 –C 6 -alkyl, such as methyl or ethyl, C 1 –C 6 -haloalkyl, such as difluoromethyl or trifluoromethyl; particularly preferably fluorine, chlorine, methyl, difluoromethyl or trifluoromethyl; R 2 is hydrogen or C 1 –C 6 -alkyl, such as methyl or ethyl; in particular hydrogen or methyl; R 3 is hydrogen or C 1 –C 6 -alkyl; in particular hydrogen; R 4 is a compound IIa or IIb

where

R 5 is halogen, OR 7 , SR 7 , SO 2 R 8 , OSO 2 R 8 , NR 10 R 11 , ONR 11 R 12 , N-linked heterocyclyl or O—(N-linked heterocyclyl), where the heterocyclyl radical of the two last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 6 is halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, di-(C 1 –C 6 -alkoxy)methyl, di-(C 1 –C 6 -alkylthio)methyl, (C 1 –C 6 -alkoxy)(C 1 –C 6 -alkylthio)methyl, hydroxyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkoxycarbonyloxy, C 1 –C 6 -alkylthio or C 1 –C 6 -haloalkylthio; or two radicals R 6 , which are linked to the same carbon, together with this carbon form a carbonyl group; R 7 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -alkynyl, C 1 –C 20 -alkylcarbonyl, C 3 –C 6 -cycloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, C 3 –C 6 -alkenyloxycarbonyl, C 1 –C 6 -alkylaminocarbonyl, C 3 –C 6 -alkenylaminocarbonyl, N,N-di-(C 1 –C 6 -alkyl)aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 - 6 -alkyl)aminocarbonyl, N—(C 1 –C 6 -alkoxy)-N-(C 1 –C 6 -alkyl) aminocarbonyl, N—(C 3 –C 6 -alkenyl)-N-(C 1 –C 6 -alkoxy) aminocarbonyl, di-(C 1 –C 6 -alkyl) aminothiocarbonyl or abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups: cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl;

phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenylcarbonyl-C 1 –C 6 -alkyl, heterocyclylcarbonyl-C 1 –C 6 -alkyl, phenylcarbonyl, heterocyclylcarbonyl, phenoxycarbonyl, heterocyclyloxycarbonyl, phenoxythiocarbonyl, heterocyclyloxythiocarbonyl, phenoxy-C 1 –C 6 -alkylcarbonyl or heterocyclyloxy-C 1 –C 6 -alkylcarbonyl, where the phenyl and the heterocyclyl radical of the 14 last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 8 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -cycloalkyl, hydroxyl, C 1 –C 6 -alkoxy, di-C 1 –C 6 -alkylamino or di-(C 1 –C 6 -haloalkyl)amino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three of the following groups:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl, heterocyclyl-C 1 –C 6 -alkyl, phenoxy, heterocyclyloxy, where the phenyl and the heterocyclyl radical of the last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 10 is C 1 –C 6 -alkyl, C 3 –C 6 -alkenyl, C 3 –C 6 -haloalkenyl, C 3 –C 6 -cycloalkyl, C 1 –C 6 -alkoxy, C 3 –C 6 -alkenyloxy or di-(C 1 –C 6 -alkyl)amino, where the abovementioned alkyl, cycloalkyl and alkoxy radicals may be partially or fully halogenated and/or may carry one to three radicals from the following group:

cyano, C 1 –C 4 -alkoxy, C 1 –C 4 -alkylthio, C 1 –C 4 -alkylcarbonyl, C 1 –C 4 -alkoxycarbonyl, hydroxycarbonyl, di-(C 1 –C 4 -alkyl)aminocarbonyl, C 1 –C 4 -alkylcarbonyloxy or C 3 –C 6 -cycloalkyl; phenyl, heterocyclyl, phenyl-C 1 –C 6 -alkyl or heterocyclyl-C 1 –C 6 -alkyl, where the phenyl or heterocyclyl radical of the four last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 11 , R 12 are C 1 –C 6 -alkyl or C 3 –C 6 -alkenyl; is 0 to 6.

Particular preference is also given to the compounds of the formula I where the variables have the following meaning, on their own or in combination:

R 1 is halogen, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, C 1 –C 6 -alkoxy, C 1 –C 6 -alkylthio, heterocyclyloxy or phenylthio, where the two last-mentioned radicals may be partially or fully halogenated and/or may carry one to three of the substituents mentioned below:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy; particularly preferably halogen, C 1 –C 6 -alkyl or C 1 –C 6 -alkylthio;

R 2 is hydrogen, C 1 –C 6 -alkyl or C 1 –C 6 -haloalkyl; particularly preferably hydrogen; R 3 is hydrogen; R 5 is halogen, OR 7 , SR 7 , SOR 8 , SO 2 R 8 , OSO 2 R 8 , OPR 8 R 9 , OPOR 8 R 9 , OPSR 8 R 9 , NR 10 R 11 or N-bonded heterocyclyl which may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy; particularly preferably halogen, OR 7 , NR 10 R 11 or N-bonded heterocyclyl which may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy; particularly preferably fluorine, OR 7 , NR 10 R 11 or N-bonded heterocyclyl selected from the group consisting of 4-morpholinyl or 4-oxo-1,4-dihydropyrid-1-yl;

›R 6 is C 1 –C 6 -alkyl…

R 6 is C 1 –C 6 -alkyl or two radicals R 6 which are attached to the same carbon form, together with this carbon, a carbonyl group; R 7 is C 1 –C 6 -alkyl, C 1 –C 20 -alkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, (C 1 –C 20 -alkylthio)carbonyl, N,N-di-(C 1 –C 6 -alkyl)aminocarbonyl, phenyl, phenylcarbonyl or phenoxy-C 1 –C 6 -alkylcarbonyl, where the phenyl radical of the three last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy; particularly preferably C 1 –C 6 -alkyl, C 1 –C 20 -alkylcarbonyl, C 1 –C 6 -alkoxycarbonyl, (C 1 –C 6 -alkylthio)carbonyl, N,N-di-(C 1 –C 6 -alkyl)aminocarbonyl, phenyl, phenylcarbonyl or phenoxy-C 1 –C 6 -alkylcarbonyl, where the phenyl radical of the three last-mentioned substituents may be partially or fully halogenated and/or may carry one to three of the following radicals: nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy; particularly preferably C 1 –C 20 -alkylthiocarbonyl; most preferably C 1 –C 6 -alkylthiocarbonyl;

R 8 ,R 9 are C 1 –C 6 -alkyl, C 1 –C 6 -alkoxy, di-(C 1 –C 6 -alkyl)amino or phenyl, where the last-mentioned radical may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

R 10 is C 1 –C 6 -alkyl or C 1 –C 6 -alkoxy; R 11 is C 1 –C 6 -alkyl; l is from 0 to 6; particularly preferably from 4 to 6; in particular 6.

Particular preference is also given to compounds of the formula I where

R 6 is nitro, halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, di-(C 1 –C 6 -alkoxy)methyl, di-(C 1 –C 6 -alkylthio)methyl, (C 1 –c 6 -alkoxy)(C 1 –C 6 -alkylthio)methyl, hydroxyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkoxycarbonyloxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfinyl, C 1 –C 6 -haloalkylsulfinyl, C 1 –C 6 -alkylsulfonyl, C 1 –C 6 -haloalkylsulfonyl, C 1 –C 6 -alkylcarbonyl, C 1 –C 6 -haloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl or C 1 –C 6 -haloalkoxycarbonyl; or two radicals R 6 , which are linked to the same carbon, together form an —O—(CH 2 ) m —O—, —O—(CH 2 ) m —O—, —O—(CH 2 ) m —S—, —S—(CH 2 ) m —S—, —O—(CH 2 ) n — or —S—(CH 2 ) n chain which may be substituted by one to three radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl;

or two radicals R 6 , which are linked to the same carbon, form a —(CH 2 ) p chain which may be interrupted by oxygen or sulfur and/or which may be substituted by one to four radicals from the following group:

halogen, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl or C 1 –C 4 -alkoxycarbonyl;

or two radicals R 6 , which are linked to the same carbon, together with this carbon form a carbonyl group.

Particular preference is given to compounds of the formula I here

R 6 is nitro, halogen, cyano, C 1 –C 6 -alkyl, C 1 –C 6 -haloalkyl, di-(C 1 –C 6 -alkoxy)methyl, di-(C 1 –C 6 -alkylthio)methyl, (C 1 –C 6 -alkoxy)(C 1 –C 6 -alkylthio)methyl, hydroxyl, C 1 –C 6 -alkoxy, C 1 –C 6 -haloalkoxy, C 1 –C 6 -alkoxycarbonyloxy, C 1 –C 6 -alkylthio, C 1 –C 6 -haloalkylthio, C 1 –C 6 -alkylsulfinyl, C 1 –C 6 -haloalkylsulfinyl, C 1 –C 6 -alkylsulfonyl, C 1 –C 6 -haloalkylsulfonyl, C 1 –C 6 -alkylcarbonyl, C 1 –C 6 -haloalkylcarbonyl, C 1 –C 6 -alkoxycarbonyl or C 1 –C 6 -haloalkoxycarbonyl; or two radicals R 6 , which are linked to the same carbon, together with this carbon form a carbonyl group.

Particular preference is also given to the compounds of the formula I where

R 5 is halogen or (C 1 –C 20 -alkylthio)carbonyloxy; particularly preferably fluorine or (C 1 –C 6 -alkylthio)carbonyloxy;

Particular preference is also given to the compounds of the formula I where

R 5 is NR 10 R 11 or N-linked heterocyclyl which may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, C 1 –C 4 -haloalkyl, C 1 –C 4 -alkoxy or C 1 –C 4 -haloalkoxy;

Particular preference is also given to the compounds of the formula I where R 4 has the following meanings:

Very particular preference is given to the compounds of the formula I where

R 5 is NR 10 R 11 or tetrahydropyrrol-1-yl, 2,3-dihydro-1H-pyrrol-1-yl, 2,5-dihydro-1H-pyrrol-1-yl, pyrrol-1-yl, tetrahydropyrazol-1-yl, tetrahydroisoxazol-2-yl, tetrahydrothiazol-2-yl, tetrahydroimidazol-1-yl, tetrahydrooxazol-3-yl, tetrahydrothiazol-3-yl, pyrazol-1-yl, imidazol-1-yl, 1,2,4-triazol-1-yl, tetrazol-1-yl, piperidin-1-yl, 4-oxo-1,4-dihydro-1-pyridyl, hexahydropyrimidin-1-yl, hexahydropyrazin-1-yl, tetrahydro-1,4-oxazin-4-yl, tetrahydro-1,2-oxazin-2-yl, succinimide, maleimide or glutarimide, where the abovementioned heterocycles may be partially or fully halogenated and/or may carry one to three of the following radicals:

nitro, cyano, C 1 –C 4 -alkyl, such as methyl or ethyl, C 1 –C 4 -haloalkyl such as chloromethyl, difluoromethyl or trifluoromethyl, C 1 –C 4 -alkoxy, such as methoxy or ethoxy or C 1 –C 4 -haloalkoxy such as difluoromethoxy or trifluoromethoxy;

R 10 C 1 –C 6 -alkoxy

Extraordinary preference is given to compounds of the formula Ia1 and Ib1 (≡I where l=0), in particular to the compounds Ia1.1 to Ia1.456 and the compounds Ib1.1 to Ib1.456, where the radical definitions R 1 to R 5 and 1 have a preferred meaning for the compounds according to the invention not only in combination with each other, but in each case also on their own.

Extraordinary preference is furthermore given to the following cyclohexenonequinolinoyl derivatives of the formula I:

the compounds of the formulae Ia2 and Ib2, in particular the compounds Ia2.1 to Ia2.456 and the compounds Ib2.1 to Ib2.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “5,5-dimethyl”.

the compounds of the formulae Ia3 and Ib3, in particular the compounds Ia3.1 to Ia3.456 and the compounds Ib3.1 to Ib3.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “5-methyl”.

›the compounds of the formulae Ia4 and Ib4…

the compounds of the formulae Ia4 and Ib4, in particular the compounds Ia4.1 to Ia4.456 and the compounds Ib4.1 to Ib4.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “4,4-dimethyl”.

the compounds of the formulae Ia5 and Ib5, in particular the compounds Ia5.1 to Ia5.456 and the compounds Ib5.1 to Ib5.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “6,6-dimethyl”.

the compounds of the formulae Ia6 and Ib6, in particular the compounds Ia6.1 to Ia6.456 and the compounds Ib6.1 to Ib6.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “4,4,6,6-tetramethyl-5-oxo”.

the compounds of the formulae Ia7 and Ib7, in particular the compounds Ia7.1 to Ia7.456 and the compounds Ib7.1 to Ib7.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “6-methyl”.

the compounds of the formulae Ia8 and Ib8, in particular the compounds Ia8.1 to Ia8.456 and the compounds Ib8.1 to Ib8.456, which differ from the compounds Ia1.1 to Ia1.456 and Ib1.1 to Ib1.456, respectively, in that (R 6 ) 1 is “5-hydroxy-4,4,6,6-tetramethyl”.

The cyclohexenonequinolinoyl derivatives of the formula I can be obtained by various routes, for example by the following processes:

A. Preparation of compounds of the formula I where R 5 =halogen by reaction of cyclohexanedione derivatives of the formula III with halogenating agents:

Suitable halogenating agents are, for example, phosgene, diphosgene, triphosgene, thionyl chloride, oxalyl chloride, phosphorus chloride, phosphorus pentachloride, mesyl chloride, chloromethylene-N, N-dimethylammonium chloride, oxalyl bromide, phosphorus oxybromide etc.

B. Preparation of compounds of the formula I where R 5 =OR 7 , OSO 2 R 8 , OPR 8 R 9 , OPSR 8 R 9 or OPSR 8 R 9 by reaction of cyclohexane dione derivatives of the formula III with alkylating, sulfonylating or phosphonylating agents IVα, IVβ, IVβ, IVδ or IVε.

L 1 is a nucleophilically replaceable leaving group, such as halogen, for example chlorine or bromine, hetaryl, for example imidazolyl, carboxylate, for example acetate, or sulfonate, for example mesylate or triflate, etc.

The compounds of the formula IVα, IVβ, IVγ, IVδ or IVε can be employed directly such as, for example, in the case of the carbonyl halides, or generated in situ, for example activated carboxylic acids (using carboxylic acid and dicyclohexyl carbodiimide, etc.).

C. Preparation of compounds of the formula I where R 5 =OR 7 , SR 7 , POR 8 R 9 , NR 10 R 11 , ONR 11 R 12 , N-linked heterocyclyl or O—(N-linked heterocyclyl) by reaction of compounds of the formula I where R 5 =halogen, OSO 2 R 8 (Iα) with compounds of the formula Vα, Vβ, Vγ, Vδ, Vε, Vηor Vθ, if appropriate in the presence of a base or with prior formation of salt.

D. Preparation of compounds of the formula I where R 5 =SOR 8 , SO 2 R 8 by reaction of compounds of the formula I where R 5 =SR 8 (Iβ) with an oxidizing agent.

Suitable oxidizing agents are, for example, m-chloroperbenzoic acid, peroxy acetic acid, trifluoroperoxy acetic acid, hydrogen peroxide, if appropriate in the presence of a catalyst such as tungstate.

The following conditions apply to the abovementioned reactions: The starting materials are generally employed in equimolar amounts. However, it will also be advantageous to employ an excess of one or the other component.

If appropriate, it may be advantageous to carry out the reactions in the presence of a base. Here, the starting materials and the base are advantageously employed in equimolar amounts. An excess of base, for example 1.5 to 3 molar equivalents, based on Ia and/or Ib (where R 5 =halogen or OSO 2 R 8 ) or III may in certain cases be advantageous.

Suitable bases are tertiary alkyl amines, such as triethylamine, aromatic amines, such as pyridine, alkali metal carbonates, for example sodium carbonate or potassium carbonate, alkali metal bicarbonates, such as sodium bicarbonate and potassium bicarbonate, alkali metal alkoxides, such as sodium methoxide, sodium ethoxide, potassium tert-butoxide or alkali metal hydrides, for example sodium hydride. Preference is given to using triethylamine or pyridine.

Suitable solvents are, for example, chlorinated hydrocarbons, such as methylene chloride or 1,2-dichloroethane, aromatic hydrocarbons, for example toluene, xylene or chlorobenzene, ethers, such as diethyl ether, methyl-tert-butyl ether, tetrahydrofuran or dioxane, polar aprotic solvents, such as acetonitrile, dimethyl formamide or dimethyl sulfoxide, or esters, such as ethyl acetate, or mixtures of these.

The reaction temperature is generally in the range of from 0° C. to the boiling point of the reaction mixture.

Work-up to give the product can be carried out in a manner known per se.

Depending on the reaction conditions, the compounds Ia, Ib or mixtures of these can be formed. The latter can be separated by classical separation methods, such as, for example, crystallization, chromatography, etc.

The cyclohexanedione derivatives of the formula III are known or can be prepared by processes known per se (for example DE-A 19 532 311), for example by reacting cyclohexanones of the formula VI with an activated benzoic acid VIIa or a benzoic acid VIIb, which is preferably activated in situ, to give the acylation product which is subsequently rearranged.

L 2 is a nucleophilically replaceable leaving group, such as halogen, for example bromine or chlorine, hetaryl, for example imidazolyl or pyridyl, carboxylate, for example acetate or trifluoroacetate, etc.

The activated benzoic acid VIIa can be employed directly, such as in the case of the benzoyl halides, or be generated in situ, for example using dicyclohexyl carbodiimide, triphenylphosphine/azodicarboxylic ester, 2-pyridine disulfide/triphenyl phosphine, carbonyldiimidazole, etc.

If appropriate, it may be advantageous to carry out the acylation reaction in the presence of a base. Here, the starting materials and the auxiliary base are advantageously employed in equimolar amounts. A slight excess of the auxiliary base, for example from 1.2 to 1.5 molar equivalents, based on VII, may be advantageous in certain cases.

›Suitable auxiliary bases are tertiary alkyl amines, pyridine…

Suitable auxiliary bases are tertiary alkyl amines, pyridine or alkali metal carbonates. Suitable solvents are, for example, chlorinated hydrocarbons, such as methylene chloride or 1,2-dichloroethane, aromatic hydrocarbons, such as toluene, xylene or chlorobenzene, ethers, such as diethyl ether, methyl tert-butyl ether, tetrahydrofuran or dioxane, polar aprotic solvents, such as acetonitrile, dimethylformamide or dimethyl sulfoxide, or esters, such as ethyl acetate, or mixtures of these.

If the activated carboxylic acid component employed is a benzoyl halide, it may be advantageous to cool the reaction mixture to 0–10° C. on addition of this reaction partner. The mixture is subsequently stirred at 20–100° C., preferably at 25–50° C., until the reaction is complete. Work-up is carried out in a customary manner, for example the reaction mixture is poured into water and the product of value is extracted. Solvents which are suitable for this purpose are, in particular, methylene chloride, diethyl ether and ethyl acetate. The organic phase is dried and the solvent is removed, after which the crude ester can be employed without any further purification for the rearrangement.

The rearrangement of the esters to the compounds of the formula is advantageously carried out at 20–100° C. in a solvent and in the presence of a base and, if appropriate, with the aid of a cyano compound as catalyst.

Suitable solvents are, for example, acetonitrile, methylene chloride, 1,2-dichloroethane, dioxane, ethyl acetate, toluene or mixtures of these. Preferred solvents are acetonitrile and dioxane.

Suitable bases are tertiary amines, such as triethylamine, aromatic amines, such as pyridine, or alkali metal carbonates, such as sodium carbonate or potassium carbonate, which are preferably employed in an equimolar amount, or up to a four-fold excess, based on the ester. Preference is given to using triethylamine or alkali metal carbonate, preferably in twice the equimolar amount, based on the ester.

Suitable cyano compounds are inorganic cyanides, such as sodium cyanide or potassium cyanide, and organic cyano compounds, such as acetone cyanohydrin or trimethylsilyl cyanide. They are employed in an amount from 1 to 50 mol percent, based on the ester. Preference is given to using acetone cyanohydrin or trimethylsilyl cyanide, for example in an amount from 5 to 15, preferably 10, mol percent, based on the ester.

Work-up can be carried out in a manner known per se. For example, the reaction mixture is acidified with dilute mineral acid, such as 5% strength hydrochloric acid, or sulfuric acid, and extracted with an organic solvent, for example methylene chloride or ethyl acetate. The organic extract can be extracted with 5–10% strength alkali metal carbonate solution, for example sodium carbonate or potassium carbonate solution. The aqueous phase is acidified and the resulting precipitate is filtered off with suction and/or extracted with methylene chloride or ethyl acetate, dried and concentrated.

The benzoyl halides of the formula VIIa (where L 2 =Cl, Br) can be prepared in a manner known per se by reaction of the benzoic acids of the formula VIIb with halogenating agents, such as thionyl chloride, thionyl bromide, phosgene, diphosgene, triphosgene, oxalyl chloride, oxalyl bromide.

The benzoic acids of the formula VIIb can be prepared in a known manner from the corresponding esters by acidic or basic hydrolysis. The latter are known from the literature or can be prepared in a manner known per se.

8-Difluoromethyl-5-alkoxycarbonyl-quinolines can be obtained from the corresponding 8-aldehyde derivatives by fluorination. A suitable fluorinating agent is, inter alia, DAST. The formyl quinoline is obtained by oxidation of the corresponding bromomethyl quinoline.

Furthermore, it is possible to obtain 8-difluoromethoxy-5-alkoxycarbonyl-quinolines from the corresponding 8-hydroxy derivatives by reaction with chlorodifluoromethane. This reaction is preferably carried out in the presence of a base, such as potassium hydroxide or sodium hydroxide, in an aprotic solvent. The 8-hydroxy-5-alkoxycarbonylquinolines are obtained from 8-hydroxy-5-hydroxycarbonyl-quinoline by esterification reactions which are known per se.

›PREPARATION EXAMPLES

2-[(8-Chloroquinolin-5-yl)carbonyl]-1-chloro-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione (Compound 2.22) and

2-[(8-chloroquinolin-5-yl)chloromethylidene]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione (Compound 3.1)

4.0 g (10.8 mmol) of 2-(8-chloroquinolin-5-yl)carbonyl-4,4,6,6-tetramethylcyclohexane-1,3,5-trione were dissolved in 40 ml of dichloromethane, and 4.1 g (32.4 mmol) of oxalyl chloride and 1.5 ml of dimethylformamide were added. The mixture was stirred at 25° C. for 1.5 hours, after which the solvent was removed. This gave 3.9 g of colorless crystals. Silica gel chromatography (mobile phase: toluene/methyl-tert-butyl ether) gave:

2-[(8-chloroquinolin-5-yl)carbonyl]-1-chloro-4,4,6,6-tetra-methylcyclohex-1-ene-3,5-dione: Yield 0.65 g (colorless crystals); m.p.: 180° C.;

2-[(8-chloroquinolin-5-yl)chloromethylidene-4,4,6,6-tetramethyl-cyclohexane-1,3,5-trione: Yield: 0.35 g (colorless crystals); m.p.: 156° C.

2-[(8-Chloroquinolin-5-yl)-1-(4′-oxo-1′,4′-dihydropyrid-1′-yl)-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione (Compound 2.46) and

2-[(8-chloroquinolin-5-yl)-(4′-oxo-1′,4′-dihydropyrid-1′-yl)-methylidene]-4,4,6,6-tetramethyl-cyclohexane-1,3,5-trione (Compound 3.5)

1.0 g (2.6 mmol) of a mixture of the compounds 2.22 and 3.1 was dissolved in 25 ml of methylene chloride, 0.82 g (8.7 mmol) of 4-hydroxypyridine were added and the mixture was stirred at 40° C. for 8 hours. Insoluble components were subsequently filtered off, the solvent was removed and the residue was chromatographed over silica gel (mobile phase: methylene chloride/methanol). This gave: 2-[(8-chloroquinolin-5-yl)-4′-oxo-1′,4′-dihydropyridin-1′-yl)methylidene-4,4,6,6-tetramethylcyclohexane-1,3,5-trione: Yield 0.40 g (colorless oil);

2-[(8-chloroquinolin-5-yl)carbonyl]-1-(4′-oxo-1′,4′-dihydro-40 pyrid-1′-yl)-4,4,6,6-tetramethylcyclohex-1-ene-3,5-dione: Yield 0.25 g (colorless crystals); m.p.>210° C.

2-(8-fluoroquinolin-5-yl)carbonyl-1,5-di(ethoxycarbonyloxy)-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione (Compound 3.20) 0.12 g (4 mmol) of sodium hydride was dissolved in 10 ml of tetrahydrofuran, 0.36 g (1 mmol) of

2-[(8-fluoroquinolin-5-yl)carbonyl]-4,4,6,6-tetramethyl-1-hydroxy-cyclohexane-3,5-dione in 5 ml of tetrahydrofuran was added dropwise at room temperature and the mixture was stirred at 40° C. for 1 hour. At room temperature, 0.43 g (4 mmol) of ethyl chloroformate were subsequently added dropwise, and the mixture was heated under reflux for 3 hours. After cooling, water was added and the mixture was extracted with ethyl acetate, the organic phase was washed with 2% strength potassium carbonate solution and water and dried and the solvent was removed. This gave 0.45 g of a colorless oil).

2-[(8-Chloroquinolin-5-yl)carbonyl]-1-[(dimethylamino)carbonyl-thio]-4,4,6,6-tetramethyl-cyclo-hex-1-ene-3,5-dione (Compound 2.45) and

2-{(8-chloroquinolin-5-yl)-[(dimethylamino)carbonylthio]-methylidene}-4,4,6,6-tetramethylcyclohexane-1,3,5-trione (Compound 3.4)

0.50 g (1.3 mmol) of 2-[(8-chloroquinolin-5-yl)carbonyl]4,4,6,6-tetramethyl-cyclohexane-1,3,5-trione was dissolved in 15 ml of tetrahydrofuran, 0.52 g (5.2 mmol) of triethylamine was added and 0.32 g (2.6 mmol) of dimethylaminothiocarbonyl chloride in 5 ml of tetrahydrofuran was added dropwise. The mixture was stirred at room temperature for 30 hours, the solvent was removed, and the residue was taken up in the ethyl acetate, washed with 5% strength potassium carbonate solution and water, dried, concentrated and chromatographed over silica gel using cyclohexane/ethyl acetate. This gave

2-[(8-chloroquinolin-5-yl)carbonyl]-1-[(dimethylamino)carbonylthio]-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione: Yield 0.5 g (colorless crystals); m.p. 138° C.;

2-{(8-chloroquinolin-5-yl)-[(dimethylamino)carbonyl-thio]methyl-i dene}-4,4,6,6-tetramethylcyclohexane-1,3,5-trione: Yield: 0.2 g (colorless crystals) m.p. 75° C.

2-[(8-difluoromethylquinolin-5-yl)carbonyl]-1-chloro-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione (Compound 2.31)

›Step a) Methyl 8-formyl-5-quinolinecarboxylate

28.8 g (103 mmol) of 8-(bromomethyl)-5-quinolinecarboxylate were dissolved in 200 ml of acetonitrile, 36.1 g (309 mmol) of N-methylmorpholine N-oxide were added, the mixture was stirred at 25° C. for 7 hours and the solvent was then removed. Silica gel chromatography (mobile phase: cyclohexane/ethyl acetate) gave 12.0 g of methyl 8-formyl-5-quinolinecarboxylate (colorless crystals), m.p.: 128° C.

›Step b) 8-difluoromethyl-5-quinolinecarboxylate

0.5 g (2.3 mmol) of methyl 8-formyl-5-quinolinecarboxylate was dissolved in 50 ml of dichloroethane and, at −20° C., 1.1 g (6.8 mmol) of diethylaminosulfur trifluoride (DAST) were added dropwise. The mixture was stirred at −20° C. for 30 min and then armed to 25° C., and 50 ml of water were added dropwise. The aqueous phase was extracted with methylene chloride, the combined organic phases were washed with sodium bicarbonate solution and dried and the solvent was removed. Yield: 0.7 g of colorless crystals;

1 H-NMR (δ in ppm, d 6 -DMSO): 9.28 (d, 1H); 9.04 (s, 1H); 8.36 (d, 1H); 8.11 (d, 1H); 7.90 (t, 1H); 7.80 (brd s, 1H); 3.96 (s, 3H).

›Step c) 8-difluoromethyl-5-quinolinecarboxylic acid

0.5 g (2.0 mmol) of methyl 8-difluoromethyl-5-quinolinecarboxylate was dissolved in 5 ml of ethanol, 0.43 g (10.5 mmol) of sodium hydroxide and 1 ml of water were added, and the mixture was stirred at 25° C. for 20 hours. The solvents were subsequently removed, the residue was taken up in water, washed twice with methylene chloride and adjusted to pH 1 using 10 N hydrochloric acid, and the precipitate was filtered off with suction. Drying gave 0.5 g of 8-difluoromethyl-5-quinolinecarboxylic acid (colorless crystals);

1 H-NMR (δ in ppm, d 6 -DMSO): 9.35 (d, 1H); 9.04 (s, 1H); 8.38 (d, 1H); 8.10 (d, 1H); 7.92 (t, 1H); 7.78 (brd s, 1H).

›Step d) 2-[(8-difluoromethylquinolin-5-yl)carbonyl]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione

0.26 g (1.4 mmol) of 2,2,4,4-tetramethylcyclohexane-1,3,5-trione was dissolved in 10 ml of acetonitrile, 0.34 g (1.4 mmol) of 8-difluoromethyl-5-quinolinecarboxylic acid and 0.38 g (1.9 mmol) of dicyclohexylcarbodiimide were added and the mixture was stirred at 25° C. for 17 hours. 0.57 g (5.6 mmol) of triethylamine and 5 drops of trimethylsilyl cyanide were then added to the suspension, and stirring was continued at 25° C. for a further 25 hours. 50 ml of 5% strength potassium carbonate solution were subsequently added, the mixture was filtered, the filtrate was washed with methyl tert-butyl ether, the aqueous phase was adjusted to pH 2 using concentrated hydrochloric acid and the precipitate was filtered off, washed with water and dried. Yield: 0.25 g (colorless crystals);

1 H-NMR (δ in ppm, CDCl 3 ): 17.5 (s, 1H); 9.02 (q, 1H); 8.24 (d, 1H); 8.06 (d, 1H); 7.82 (t, 1H); 7.50 (m, 2H); 1.60 (s, 6H); 1.36 (s, 6H).

Step e) 2-[(8-Difluoromethylquinolin-5-yl)carbonyl]-1-chloro-4,4,6,6-tetramethyl-cyclohex-1-ene-3,5-dione (Compound 2.31)

0.25 g (0.65 mmol) of 2-(8-difluoromethylquinolin-5-yl)carbonyl-4,4,6,6-tetramethyl-cyclohexane-1,3,5-trione was dissolved in 15 ml of dichloromethane and 0.25 g (1.95 mmol) of oxalyl chloride and 7 drops of dimethylformamide were added. The mixture was stirred at 25° C. for 17 hours, after which the solvent was removed. This gave 0.2 g of colorless crystals.

Preparation of the Precursor 2-[(8-difluoromethoxyquinolin-5-yl)carbonyl]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione

›Step a) Methyl 8-hydroxy-5-quinolincarboxylate

16.25 g (86 mmol) of 8-hydroxy-5-quinolinecarboxylic acid were dissolved in 70 ml of methanol, 3 ml of concentrated sulfuric acid were added and the mixture was heated under reflux for 25 hours. The solvent was then removed and the residue was taken up in ice-water, adjusted to a pH of 8 using sodium carbonate solution and filtered hot. The residue was extracted with methyl-tert-butyl ether for 7 hours on a jacketed Soxhlet extractor, and the solvent was subsequently removed from the extract. This gave 6.8 g of a brown powder;

1 H-NMR (δ in ppm, d 6 -DMSO): 9.38 (d, 1H); 8.90 (d, 1H); 8.26 (d, 1H); 7.71 (dd, 1H); 7.15 (d, 1H); 3.93 (s, 3H).

›Step b) Methyl 8-difluoromethoxy-5-quinolinecarboxylate

1.0 g (5.0 mmol) of methyl 8-hydroxy-5-quinolinecarboxylate was dissolved in 20 ml of dimethylformamide, 0.76 g (5.5 mmol) of potassium carbonate was added and 14 g of chlorodifluoromethane were introduced at 40° C. over a period of 2 hours. Solid components were then filtered off, the solvent was removed and the residue was washed with water and dried. This gave 0.75 g of a brown powder;

1 H-NMR (δ in ppm, CDCl 3 ): 9.45 (d, 1H); 9.00 (d, 1H); 8.30 (d, 1H); 7.61 (dd, 1H); 7.49 (d, 1H); 7.18 (t, 1H); 3.99 (s, 3H).

›Step c) 8-difluoromethoxy-5-quinolinecarboxylic acid

0.7 g (2.8 mmol) of methyl 8-difluoromethoxy-5-quinolinecarboxylate was suspended in 15 ml of water and 0.4 g (10 mmol) of sodium hydroxide was added. The mixture was stirred at 25° C. for 20 hours and then filtered off, and the filtrate was washed with methyl tert-butyl ether. The aqueous phase was adjusted to pH 3 using concentrated hydrochloric acid and filtered off, and the residue was dried. This gave 0.45 g of a colorless powder;

1 H-NMR (δ in ppm, d 6 -DMSO): 13.5 (br, 1H); 9.39 (d, 1H); 9.03 (d, 1H); 8.32 (d, 1H); 7.78 (dd, 1H); 7.62 (d, 1H); 7.60 (t, 1H).

›Step d) 2-[(8-difluoromethoxyquinolin-5-yl)carbonyl]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione · 1 of 3

0.4 g (1.7 mmol) of 8-difluoromethoxy-5-quinolinecarboxylic acid was dissolved in 20 ml of acetonitrile, 0.4 g (1.9 mmol) of N,N-dicyclohexylcarbodiimide and 0.3 g (1.7 mmol) of 2,2,4,4-tetramethylcyclohexane-1,3,5-trione were added and the mixture was stirring at 25° C. for 20 hours. 0.4 g (4.0 mmol) of triethylamine and 2 drops of trimethylsilyl cyanide were then added, and stirring was continued at 30–35° C. for a further 3 hours. The precipitate was filtered off, and the filtrate was concentrated, 20 ml of 5% strength potassium carbonate solution were added and the mixture was washed with methyl tert-butyl ether. The aqueous phase was subsequently adjusted to pH 3 using concentrated hydrochloric acid and extracted with ethyl acetate. The solvent was removed and the residue was chromatographed over silica gel (mobile phase: methylene chloride/methanol). This gave 0.2 g of a colorless powder;

35 1 H-NMR (δ in ppm, CDCl 3 ): 16.5 (br, 1H); 9.02 (d, 1H); 8.30 (d, 1H); 7.51 (m, 2H); 7.21 (d, 1H); 7.17 (t, 1H); 1.60 (s, 6H); 1.35 (s, 6H).

In addition to the cyclohexenone quinolinoyl derivatives of the formula I described above, further derivatives which were prepared or are preparable in a similar manner or in a manner known per se are listed in Tables 2 and 3:

The compounds of the formula I and their agriculturally useful salts are suitable, both in the form of isomer mixtures and in the form of the pure isomers, as herbicides. The herbicidal compositions comprising compounds of the formula I control vegetation on non-crop areas very efficiently, especially at high rates of application. They act against broad-leaved weeds and harmful grasses in crops such as wheat, rice, maize, soya and cotton without causing any significant damage to the crop plants. This effect is mainly observed at low rates of application.

Depending on the application method used, the compounds of the formula I, or the compositions comprising them, can additionally be employed in a further number of crop plants for eliminating undesirable plants. Examples of suitable crops are the following:

Allium cepa, Ananas comosus, Arachis hypogaea, Asparagus officinalis, Beta vulgaris spec. altissima, Beta vulgaris spec. rapa, Brassica napus var. napus, Brassica napus var. napobrassica, Brassica rapa var. silvestris, Camellia sinensis, Carthamus tinctorius, Carya illinoinensis, Citrus limon, Citrus sinensis, Coffea arabica ( Coffea canephora, Coffea liberica ), Cucumis sativus, Cynodon dactylon, Daucus carota, Elaeis guineensis, Fragaria vesca, Glycine max, Gossypium hirsutum , ( Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium ), Helianthus annuus, Hevea brasiliensis, Hordeum vulgare, Humulus lupulus, Ipomoea batatas, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Manihot esculenta, Medicago sativa, Musa spec., Nicotiana tabacum ( N.rustica ), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Picea abies, Pinus spec., Pisum sativum, Prunus avium, Prunus persica, Pyrus communis, Ribes sylvestre, Ricinus communis, Saccharum officinarum, Secale cereale, Solanum tuberosum, Sorghum bicolor ( s. vulgare ), Theobroma cacao, Trifolium pratense, Triticum aestivum, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.

In addition, the compounds of the formula I may also be used in crops which tolerate the action of herbicides owing to breeding, including genetic engineering methods.

The compounds of the formula I, or the herbicidal compositions comprising them, can be used for example in the form of ready-to-spray aqueous solutions, powders, suspensions, also highly-concentrated aqueous, oily or other suspensions or dispersions, emulsions, oil dispersions, pastes, dusts, materials for broadcasting or granules, by means of spraying, atomizing, dusting, broadcasting or watering. The use forms depend on the intended aims; in any case, they should guarantee a very fine distribution of the active compounds according to the invention.

The herbicidal compositions comprise a herbicidally effective amount of at least one compound of the formula I or of an agriculturally useful salt of I, and auxiliaries which are customary for the formulation of crop protection agents.

Essentially, suitable inert auxiliaries include: mineral oil fractions of medium to high boiling point, such as kerosene and diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, e.g. paraffin, tetrahydronaphthalene, alkylated naphthalenes and their derivatives, alkylated benzenes and their derivatives, alcohols such as methanol, ethanol, propanol, butanol and cyclohexanol, ketones such as cyclohexanone, or strongly polar solvents, e.g. amines such as N-methylpyrrolidone, and water.

Aqueous use forms can be prepared from emulsion concentrates, suspensions, pastes, wettable powders or water-dispersible granules by adding water. To prepare emulsions, pastes or oil dispersions, the cyclohexenonequinolinoyl derivatives of the formula I, either as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetting agent, tackifier, dispersant or emulsifier. Alternatively, it is possible to prepare concentrates comprising active substance, wetting agent, tackifier, dispersant or emulsifier and, if desired, solvent or oil, which are suitable for dilution with water.

Suitable surfactants are the alkali metal salts, alkaline earth metal salts and ammonium salts of aromatic sulfonic acids, e.g. ligno-, phenol-, naphthalene- and dibutylnaphthalenesulfonic acid, and of fatty acids, alkyl- and alkylarylsulfonates, alkyl sulfates, lauryl ether sulfates and fatty alcohol sulfates, and salts of sulfated hexa-, hepta- and octadecanols, and also of fatty alcohol glycol ethers, condensates of sulfonated naphthalene and its derivatives with formaldehyde, condensates of naphthalene, or of the naphthalenesulfonic acids with phenol and formaldehyde, polyoxyethylene octylphenol ether, ethoxylated isooctyl-, octyl- or nonylphenol, alkylphenyl or tributylphenyl polyglycol ether, alkylaryl polyether alcohols, isotridecyl alcohol, fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers or polyoxypropylene alkyl ethers, lauryl alcohol polyglycol ether acetate, sorbitol esters, lignin-sulfite waste liquors or methylcellulose. Powders, materials for broadcasting and dusts can be prepared by mixing or grinding the active substances together with a solid carrier.

›Step d) 2-[(8-difluoromethoxyquinolin-5-yl)carbonyl]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione · 2 of 3

Granules, e.g. coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active compounds to solid carriers. Solid carriers are mineral earths, such as silicas, silica gels, silicates, talc, kaolin, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers such as ammonium sulfate, ammonium phosphate and ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders, or other solid carriers.

The concentrations of the compounds of the formula I in the ready-to-use preparations can be varied within wide ranges. In general, the formulations comprise from about 0.001 to 98% by weight, preferably 0.01 to 95% by weight of at least one active compound. The active compounds are employed in a purity of from 90% to 100%, preferably 95% to 100% (according to the NMR spectrum).

The following formulation examples illustrate the production of such preparations:

I. 20 parts by weight of the compound No. 2.2 are dissolved in a mixture composed of 80 parts by weight of alkylated benzene, 10 parts by weight of the adduct of 8 to 10 mol of ethylene oxide to 1 mol of oleic acid N-monoethanolamide, 5 parts by weight of calcium dodecylbenzenesulfonate and 5 parts by weight of the adduct of 40 mol of ethylene oxide to 1 mol of castor oil. Pouring the solution into 100,000 parts by weight of water and finely distributing it therein gives an aqueous dispersion which comprises 0.02% by weight of the active compound.

II. 20 parts by weight of the compound No. 2.4 are dissolved in a mixture composed of 40 parts by weight of cyclohexanone, 30 parts by weight of isobutanol, 20 parts by weight of the adduct of 7 mol of ethylene oxide to 1 mol of isooctylphenol and 10 parts by weight of the adduct of 40 mol of ethylene oxide to 1 mol of castor oil. Pouring the solution into 100,000 parts by weight of water and finely distributing it therein gives an aqueous dispersion which comprises 0.02% by weight of the active compound.

III. 20 parts by weight of the compound No. 2.16 are dissolved in a mixture composed of 25 parts by weight of cyclohexanone, 65 parts by weight of a mineral oil fraction of boiling point 210 to 280° C. and 10 parts by weight of the adduct of 40 mol of ethylene oxide to 1 mol of castor oil. Pouring the solution into 100,000 parts by weight of water and finely distributing it therein gives an aqueous dispersion which comprises 0.02% by weight of the active compound.

IV. 20 parts by weight of the compound No. 2.18 are mixed thoroughly with 3 parts by weight of sodium diisobutylnaphthalenesulfonate, 17 parts by weight of the sodium salt of a lignosulfonic acid from a sulfite waste liquor and 60 parts by weight of pulverulent silica gel, and the mixture is ground in a hammer mill. Finely distributing the mixture in 20,000 parts by weight of water gives a spray mixture which comprises 0.1% by weight of the active compound.

V. 3 parts by weight of the compound No. 2.22 are mixed with 97 parts by weight of finely divided kaolin. This gives a dust which comprises 3% by weight of the active compound.

VI. 20 parts by weight of the compound No. 2.46 are mixed intimately with 2 parts by weight of the calcium salt of dodecylbenzenesulfonate, 8 parts by weight of fatty alcohol polyglycol ether, 2 parts by weight of the sodium salt of a phenol/urea/formaldehyde condensate and 68 parts by weight of a paraffinic mineral oil. This gives a stable oily dispersion.

VII. 1 part by weight of the compound No. 3.1 is dissolved in a mixture composed of 70 parts by weight of cyclohexanone, 20 parts by weight of ethoxylated isooctylphenol and 10 parts by weight of ethoxylated castor oil. This gives a stable emulsion concentrate.

VIII. 1 part by weight of the compound No. 3.4 is dissolved in a mixture composed of 80 parts by weight of cyclohexanone and 20 parts by weight of Wettol® EM 31 (nonionic emulsifier based on ethoxylated castor oil). This gives a stable emulsion concentrate.

The compounds of the formula I or the herbicidal compositions can be applied pre- or post-emergence. If the active compounds are less well tolerated by certain crop plants, application techniques may be used in which the herbicidal compositions are sprayed, with the aid of the spraying equipment, in such a way that they come into contact as little as possible, if at all, with the leaves of the sensitive crop plants, while the active compounds reach the leaves of undesirable plants growing underneath, or the bare soil surface (post-directed, lay-by).

The application rates of the compound of the formula I are from 0.001 to 3.0, preferably 0.01 to 1.0 kg/ha of active substance (a.s.), depending on the control target, the season, the target plants and the growth stage.

To widen the activity spectrum and to achieve synergistic effects, the cyclohexenonequinolinoyl derivatives of the formula I may be mixed with a large number of representatives of other herbicidal or growth-regulating active compound groups and then applied concomitantly. Suitable components for mixtures are, for example, 1,2,4-thiadiazoles, 1,3,4-thiadiazoles, amides, aminophosphoric acid and its derivatives, aminotriazoles, anilides, (het)aryloxyalkanoic acids and their derivatives, benzoic acid and its derivatives, benzothiadiazinones, 2-aroyl-1,3-cyclohexanediones, hetaryl aryl ketones, benzylisoxazolidinones, meta-CF 3 -phenyl derivatives, carbamates, quinolinecarboxylic acid and its derivatives, chloroacetanilides, cyclohexenone oxime ether derivatives, diazines, dichloropropionic acid and its derivatives, dihydrobenzofurans, dihydrofuran-3-ones, dinitroanilines, dinitrophenols, diphenyl ethers, dipyridyls, halocarboxylic acids and their derivatives, ureas, 3-phenyluracils, imidazoles, imidazolinones, N-phenyl-3,4,5,6-tetrahydrophthalimides, oxadiazoles, oxiranes, phenols, aryloxy- and hetaryloxyphenoxypropionic esters, phenylacetic acid and its derivatives, phenylpropionic acid and its derivatives, pyrazoles, phenylpyrazoles, pyridazines, pyridinecarboxylic acid and its derivatives, pyrimidyl ethers, sulfonamides, sulfonylureas, triazines, triazinones, triazolinones, triazolecarboxamides and uracils.

›Step d) 2-[(8-difluoromethoxyquinolin-5-yl)carbonyl]-4,4,6,6-tetramethylcyclohexane-1,3,5-trione · 3 of 3

It may furthermore be advantageous to apply the compounds of the formula I, alone or else concomitantly in combination with other herbicides, in the form of a mixture with other crop protection agents, for example together with agents for controlling pests or phytopathogenic fungi or bacteria. Also of interest is the miscibility with mineral salt solutions, which are employed for treating nutritional and trace element deficiencies. Non-phytotoxic oils and oil concentrates may also be added.

Use Examples

The herbicidal activity of the cyclohexenonequinolinoyl derivatives of the formula I was demonstrated by the following greenhouse experiments:

The culture containers used were plastic pots containing loamy sand with approximately 3.0% of humus as the substrate. The seeds of the test plants were sown separately for each species.

For the pre-emergence treatment, the active compounds, which had been suspended or emulsified in water, were applied directly after sowing by means of finely distributing nozzles. The containers were irrigated gently to promote germination and growth and subsequently covered with transparent plastic hoods until the plants had rooted. This cover caused uniform germination of the test plants, unless this was adversely affected by the active compounds.

For the post-emergence treatment, the test plants were first grown to a height of 3 to 15 cm, depending on the plant habit, and only then treated with the active compounds which had been suspended or emulsified in water. The test plants were for this purpose either sown directly and grown in the same containers, or they were first grown separately as seedlings and transplanted into the test containers a few days prior to treatment. The application rate for the post-emergence treatment was 0.25 or 0.125 kg of a.s. (active substance)/ha.

Depending on the species, the plants were kept at 10–25° C. or 20–35° C. The test period extended over 2 to 4 weeks. During this time, the plants were tended, and their response to the individual treatments was evaluated.

The evaluation was carried out using a scale from 0 to 100. 100 means no emergence of the plants, or complete destruction of at least the aerial parts and 0 means no damage, or normal course of growth.

The plants used in the greenhouse experiments are composed of the following species:

At application rates of 0.25 and 0.125 kg of a.s./ha, the compounds 2.2, 2.4 and 2.16, applied post-emergence, showed very good activity against harmful plants such as giant foxtail, green foxtail and black nightshade. Furthermore, the compounds 2.2 and 2.4 controlled velvet leaf and morning glory very efficiently. Compound 2.16 additionally showed excellent activity against the weeds lambsquarters and catchweed bedstraw.

›Tables in the description — 3
TABLE 1 — Ia1 Ib1
No.R 1R 2R 3R 5
Ia1.1 or Ib1.1CH 3HHF
Ia1.2 or Ib1.2CH 3HHCl
Ia1.3 or Ib1.3CH 3HHBr
Ia1.4 or Ib1.4CH 3HHI
Ia1.5 or Ib1.5CH 3HHSCH 3
Ia1.6 or Ib1.6CH 3HHSCH 2 CH 3
Ia1.7 or Ib1.7CH 3HHSCO(N(CH 3 ) 2 ) 2
Ia1.8 or Ib1.8CH 3HHSO 2 CH 3
Ia1.9 or Ib1.9CH 3HHSO 2 CH 2 CH 3
Ia1.10 or Ib1.10CH 3HHSC 6 H 5
Ia1.11 or Ib1.11CH 3HHS(4-CH 3 —C 6 H 4 )
Ia1.12 or Ib1.12CH 3HHS(4-Cl—C 6 H 4 )
Ia1.13 or Ib1.13CH 3HHSO 2 C 6 H 5
Ia1.14 or Ib1.14CH 3HHSO 2 (4-CH 3 —C 6 H 4 )
Ia1.15 or Ib1.15CH 3HHSO 2 (4-Cl—C 6 H 4 )
Ia1.16 or Ib1.16CH 3HH4-morpholinyl
Ia1.17 or Ib1.17CH 3HH1-pyrrolidinyl
Ia1.18 or Ib1.18CH 3HH1-(1,2,4-triazolyl)
Ia1.19 or Ib1.19CH 3HH1-imidazolyl
Ia1.20 or Ib1.20CH 3HH1-pyrazolyl
Ia1.21 or Ib1.21CH 3HH4-oxo-1,4-dihydro-1-
pyridyl
Ia1.22 or Ib1.22CH 3HHN(OCH 3 )CH 3
Ia1.23 or Ib1.23CH 3HH2-tetrahydroisoxazolyl
Ia1.24 or Ib1.24CH 3HHN(CH 3 )N(CH 3 ) 2
Ia1.25 or Ib1.25CH 3HHN(CH 2 CH═CH 2 )N(CH 3 ) 2
Ia1.26 or Ib1.26CH 3HHOPO(OCH 3 ) 2
Ia1.27 or Ib1.27CH 3HHOPO(OCH 2 CH 3 ) 2
Ia1.28 or Ib1.28CH 3HHOPO(N(CH 3 ) 2 ) 2
Ia1.29 or Ib1.29CH 3HHOPO(OC 6 H 5 ) 2
Ia1.30 or Ib1.30CH 3HHOPO(CH 3 ) 2
Ia1.31 or Ib1.31CH 3HHOPO(CH 2 CH 3 ) 2
Ia1.32 or Ib1.32CH 3HHOPO(C 6 H 5 ) 2
Ia1.33 or Ib1.33CH 3HHOPS(OCH 3 ) 2
Ia1.34 or Ib1.34CH 3HHOPS(OCH 2 CH 3 ) 2
Ia1.35 or Ib1.35CH 3HHOP(OCH 3 ) 2
Ia1.36 or Ib1.36CH 3HHOP(OCH 2 CH 3 ) 2
Ia1.37 or Ib1.37CH 3HHPO(OCH 3 ) 2
Ia1.38 or Ib1.38CH 3HHPO(OCH 2 CH 3 ) 2
Ia1.39 or Ib1.39CH 3HHPO(C 6 H 5 ) 2
Ia1.40 or Ib1.40CH 3HHOCH 3
Ia1.41 or Ib1.41CH 3HHOCH 2 CH 3
Ia1.42 or Ib1.42CH 3HHOCH 2 C 6 H 5
Ia1.43 or Ib1.43CH 3HHOCH 2 (2-furyl)
Ia1.44 or Ib1.44CH 3HHOCH 2 (3-furyl)
Ia1.45 or Ib1.45CH 3HHOCOOCH 3
Ia1.46 or Ib1.46CH 3HHOCOOCH 2 CH 3
Ia1.47 or Ib1.47CH 3HHOCOOCH(CH 3 ) 2
Ia1.48 or Ib1.48CH 3HHOCOOC 6 H 5
Ia1.49 or Ib1.49CH 3HHOCOOC(CH 3 ) 3
Ia1.50 or Ib1.50CH 3HHOCSOC 6 H 5
Ia1.51 or Ib1.51CH 3HHOCSN(CH 3 ) 2
Ia1.52 or Ib1.52CH 3HHOCON(CH 3 ) 2
Ia1.53 or Ib1.53CH 3HHOCOSCH 3
Ia1.54 or Ib1.54CH 3HHON(CH 3 ) 2
Ia1.55 or Ib1.55CH 3HHO-1-piperidyl
Ia1.56 or Ib1.56CH 3HHOCOCH 3
Ia1.57 or Ib1.57CH 3HHOCOCH 2 CH 3
Ia1.58 or Ib1.58CH 3HHOCOCH(CH 3 ) 2
Ia1.59 or Ib1.59CH 3HHOCOC(CH 3 )3
Ia1.60 or Ib1.60CH 3HHOCO(CH 2 ) 6 CH 3
Ia1.61 or Ib1.61CH 3HHOCO(CH 2 ) 7 CH 3
Ia1.62 or Ib1.62CH 3HHOCO(CH 2 ) 16 CH 3
Ia1.63 or Ib1.63CH 3HHOCO(CH 2 ) 14 CH 3
Ia1.64 or Ib1.64CH 3HHOCOCH 2 CH 2 CH═CH 2
Ia1.65 or Ib1.65CH 3HHOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.66 or Ib1.66CH 3HHOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.67 or Ib1.67CH 3HHOCOcyclopropyl
Ia1.68 or Ib1.68CH 3HHOCOcyclopentyl
Ia1.69 or Ib1.69CH 3HHOCOcyclohexyl
Ia1.70 or Ib1.70CH 3HHOCOC 6 H 5
Ia1.71 or Ib1.71CH 3HHOCO(2-tetrahydrofuryl)
Ia1.72 or Ib1.72CH 3HHOCO(2-furyl)
Ia1.73 or Ib1.73CH 3HHOCO(2-thienyl)
Ia1.74 or Ib1.74CH 3HHOCO(3-pyridyl)
Ia1.75 or Ib1.75CH 3HHOSO 2 CH 3
Ia1.76 or Ib1.76CH 3HHOSO 2 CH 2 CH 3
Ia1.77 or Ib1.77FHHF
Ia1.78 or Ib1.78FHHCl
Ia1.79 or Ib1.79FHHBr
Ia1.80 or Ib1.80FHHI
Ia1.81 or Ib1.81FHHSCH 3
Ia1.82 or Ib1.82FHHSCH 2 CH 3
Ia1.83 or Ib1.83FHHSCO(N(CH 3 ) 2 ) 2
Ia1.84 or Ib1.84FHHSO 2 CH 3
Ia1.85 or Ib1.85FHHSO 2 CH 2 CH 3
Ia1.86 or Ib1.86FHHSC 6 H 5
Ia1.87 or Ib1.87FHHS(4-CH 3 —C 6 H 4 )
Ia1.88 or Ib1.88FHHS(4-Cl—C 6 H 4 )
Ia1.89 or Ib1.89FHHSO 2 C 6 H 5
Ia1.90 or Ib1.90FHHSO 2 (4-CH 3 —C 6 H 4 )
Ia1.91 or Ib1.91FHHSO 2 (4-Cl—C 6 H 4 )
Ia1.92 or Ib1.92FHH4-morpholinyl
Ia1.93 or Ib1.93FHH1-pyrrolidinyl
Ia1.94 or Ib1.94FHH1-(1,2,4-triazolyl)
Ia1.95 or Ib1.95FHH1-imidazolyl
Ia1.96 or Ib1.96FHH1-pyrazolyl
Ia1.97 or Ib1.97FHH4-oxo-1,4-dihydro-1-
pyridyl
Ia1.98 or Ib1.98FHHN(OCH 3 )CH 3
Ia1.99 or Ib1.99FHH2-tetrahydroisoxazolyl
Ia1.100 or Ib1.100FHHN(CH 3 )N(CH 3 ) 2
Ia1.101 or Ib1.101FHHN(CH 2 CH═CH 2 )N(CH 3 ) 2
Ia1.102 or Ib1.102FHHOPO(OCH 3 ) 2
Ia1.103 or Ib1.103FHHOPO(N(CH 3 ) 2 ) 2
Ia1.104 or Ib1.104FHHOPO(OCH 2 CH 3 ) 2
Ia1.105 or Ib1.105FHHOPO(OC 6 H 5 ) 2
Ia1.106 or Ib1.106FHHOPO(CH 3 ) 2
Ia1.107 or Ib1.107FHHOPO(CH 2 CH 3 ) 2
Ia1.108 or Ib1.108FHHOPO(C 6 H 5 ) 2
Ia1.109 or Ib1.109FHHOPS(OCH 3 ) 2
Ia1.110 or Ib1.110FHHOPS(OCH 2 CH 3 ) 2
Ia1.111 or Ib1.111FHHOP(OCH 3 ) 2
Ia1.112 or Ib1.112FHHOP(OCH 2 CH 3 ) 2
Ia1.113 or Ib1.113FHHPO(OCH 3 ) 2
Ia1.114 or Ib1.114FHHPO(OCH 2 CH 3 ) 2
Ia1.115 or Ib1.115FHHPO(C 6 H 5 ) 2
Ia1.116 or Ib1.116FHHOCH 3
Ia1.117 or Ib1.117FHHOCH 2 CH 3
Ia1.118 or Ib1.118FHHOCH 2 C 6 H 5
Ia1.119 or Ib1.119FHHOCH 2 (2-furyl)
Ia1.120 or Ib1.120FHHOCH 2 (3-furyl)
Ia1.121 or Ib1.121FHHOCOOCH 3
Ia1.122 or Ib1.122FHHOCOOCH 2 CH 3
Ia1.123 or Ib1.123FHHOCOOCH(CH 3 ) 2
Ia1.124 or Ib1.124FHHOCOOC 6 H 5
Ia1.125 or Ib1.125FHHOCOOC(CH 3 ) 3
Ia1.126 or Ib1.126FHHOCSOC 6 H 5
Ia1.127 or Ib1.127FHHOCSN(CH 3 ) 2
Ia1.128 or Ib1.128FHHOCON(CH 3 ) 2
Ia1.129 or Ib1.129FHHOCOSCH 3
Ia1.130 or Ib1.130FHHON(CH 3 ) 2
Ia1.131 or Ib1.131FHHO-1-piperidyl
Ia1.132 or Ib1.132FHHOCOCH 3
Ia1.133 or Ib1.133FHHOCOCH 2 CH 3
Ia1.134 or Ib1.134FHHOCOCH(CH 3 ) 2
Ia1.135 or Ib1.135FHHOCOC(CH 3 ) 3
Ia1.136 or Ib1.136FHHOCO(CH 2 ) 6 CH 3
Ia1.137 or Ib1.137FHHOCO(CH 2 ) 7 CH 3
Ia1.138 or Ib1.138FHHOCO(CH 2 ) 16 CH 3
Ia1.139 or Ib1.139FHHOCO(CH 2 ) 14 CH 3
Ia1.140 or Ib1.140FHHOCOCH 2 CH 2 CH═CH 2
Ia1.141 or Ib1.141FHHOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.142 or Ib1.142FHHOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.143 or Ib1.143FHHOCOcyclopropyl
Ia1.144 or Ib1.144FHHOCOcyclopentyl
Ia1.145 or Ib1.145FHHOCOcyclohexyl
Ia1.146 or Ib1.146FHHOCOC 6 H 5
Ia1.147 or Ib1.147FHHOCO(2-tetrahydrofuryl)
Ia1.148 or Ib1.148FHHOCO(2-furyl)
Ia1.149 or Ib1.149FHHOCO(2-thienyl)
Ia1.150 or Ib1.150FHHOCO(3-pyridyl)
Ia1.151 or Ib1.151FHHOSO 2 CH 3
Ia1.152 or Ib1.152FHHOSO 2 CH 2 CH 3
Ia1.153 or Ib1.153CF 3HHF
Ia1.154 or Ib1.154CF 3HHCl
Ia1.155 or Ib1.155CF 3HHBr
Ia1.156 or Ib1.156CF 3HHI
Ia1.157 or Ib1.157CF 3HHSCH 3
Ia1.158 or Ib1.158CF 3HHSCH 2 CH 3
Ia1.159 or Ib1.159CF 3HHSCO(N(CH 3 ) 2 ) 2
Ia1.160 or Ib1.160CF 3HHSO 2 CH 3
Ia1.161 or Ib1.161CF 3HHSO 2 CH 2 CH 3
Ia1.162 or Ib1.162CF 3HHSC 6 H 5
Ia1.163 or Ib1.163CF 3HHS(4-CH 3 —C 6 H 4 )
Ia1.164 or Ib1.164CF 3HHS(4-Cl—C 6 H 4 )
Ia1.165 or Ib1.165CF 3HHSO 2 C 6 H 5
Ia1.166 or Ib1.166CF 3HHSO 2 (4-CH 3 —C 6 H 4 )
Ia1.167 or Ib1.167CF 3HHSO 2 (4-Cl—C 6 H 4 )
Ia1.168 or Ib1.168CF 3HH4-morpholinyl
Ia1.169 or Ib1.169CF 3HH1-pyrrolidinyl
Ia1.170 or Ib1.170CF 3HH1-(1,2,4-triazolyl)
Ia1.171 or Ib1.171CF 3HH1-imidazolyl
Ia1.172 or Ib1.172CF 3HH1-pyrazolyl
Ia1.173 or Ib1.173CF 3HH4-oxo-1,4-dihydro-1-
pyridyl
Ia1.174 or Ib1.174CF 3HHN(OCH 3 )CH 3
Ia1.175 or Ib1.175CF 3HH2-tetrahydroisoxazolyl
Ia1.176 or Ib1.176CF 3HHN(CH 3 )N(CH 3 ) 2
Ia1.177 or Ib1.177CF 3HHN(CH 2 CHCH 2 )N(CH 3 ) 2
Ia1.178 or Ib1.178CF 3HHOPO(OCH 3 ) 2
Ia1.179 or Ib1.179CF 3HHOPO(OCH 2 CH 3 ) 2
Ia1.180 or Ib1.180CF 3HHOPO(N(CH 3 ) 2 ) 2
Ia1.181 or Ib1.181CF 3HHOPO(OC 6 H 5 ) 2
Ia1.182 or Ib1.182CF 3HHOPO(CH 3 ) 2
Ia1.183 or Ib1.183CF 3HHOPO(CH 2 CH 3 ) 2
Ia1.184 or Ib1.184CF 3HHOPO(C 6 H 5 ) 2
Ia1.185 or Ib1.185CF 3HHOPS(OCH 3 ) 2
Ia1.186 or Ib1.186CF 3HHOPS(OCH 2 CH 3 ) 2
Ia1.187 or Ib1.187CF 3HHOP(OCH 3 ) 2
Ia1.188 or Ib1.188CF 3HHOP(OCH 2 CH 3 ) 2
Ia1.189 or Ib1.189CF 3HHPO(OCH 3 ) 2
Ia1.190 or Ib1.190CF 3HHPO(OCH 2 CH 3 ) 2
Ia1.191 or Ib1.191CF 3HHPO(C 6 H 5 ) 2
Ia1.192 or Ib1.192CF 3HHOCH 3
Ia1.193 or Ib1.193CF 3HHOCH 2 CH 3
Ia1.194 or Ib1.194CF 3HHOCH 2 C 6 H 5
Ia1.195 or Ib1.195CF 3HHOCH 2 (2-furyl)
Ia1.196 or Ib1.196CF 3HHOCH 2 (3-furyl)
Ia1.197 or Ib1.197CF 3HHOCOOCH 3
Ia1.198 or Ib1.198CF 3HHOCOOCH 2 CH 3
Ia1.199 or Ib1.199CF 3HHOCOOCH(CH 3 ) 2
Ia1.200 or Ib1.200CF 3HHOCOOC 6 H 5
Ia1.201 or Ib1.201CF 3HHOCOOC(CH 3 ) 3
Ia1.202 or Ib1.202CF 3HHOCSOC 6 H 5
Ia1.203 or Ib1.203CF 3HHOCSN(CH 3 ) 2
Ia1.204 or Ib1.204CF 3HHOCON(CH 3 ) 2
Ia1.205 or Ib1.205CF 3HHOCOSCH 3
Ia1.206 or Ib1.206CF 3HHON(CH 3 ) 2
Ia1.207 or Ib1.207CF 3HHO-1-piperidyl
Ia1.208 or Ib1.208CF 3HHOCOCH 3
Ia1.209 or Ib1.209CF 3HHOCOCH 2 CH 3
Ia1.210 or Ib1.210CF 3HHOCOCHC(CH 3 ) 2
Ia1.211 or Ib1.211CF 3HHOCOC(CH 3 ) 3
Ia1.212 or Ib1.212CF 3HHOCO(CH 2 ) 6 CH 3
Ia1.213 or Ib1.213CF 3HHOCO(CH 2 ) 7 CH 3
Ia1.214 or Ib1.214CF 3HHOCO(CH 2 ) 16 CH 3
Ia1.215 or Ib1.215CF 3HHOCO(CH 2 ) 14 CH 3
Ia1.216 or Ib1.216CF 3HHOCOCH 2 CH 2 CH═CH 2
Ia1.217 or Ib1.217CF 3HHOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.218 or Ib1.218CF 3HHOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.219 or Ib1.219CF 3HHOCOcyclopropyl
Ia1.220 or Ib1.220CF 3HHOCOcyclopentyl
Ia1.221 or Ib1.221CF 3HHOCOcyclohexyl
Ia1.222 or Ib1.222CF 3HHOCOC 6 H 5
Ia1.223 or Ib1.223CF 3HHOCO(2-tetrahydrofuryl)
Ia1.224 or Ib1.224CF 3HHOCO(2-furyl)
Ia1.225 or Ib1.225CF 3HHOCO(2-thienyl)
Ia1.226 or Ib1.226CF 3HHOCO(3-pyridyl)
Ia1.227 or Ib1.227CF 3HHOSO 2 CH 3
Ia1.228 or Ib1.228CF 3HHOSO 2 CH 2 CH 3
Ia1.229 or Ib1.229ClHHF
Ia1.230 or Ib1.230ClHHCl
Ia1.231 or Ib1.231ClHHBr
Ia1.232 or Ib1.232ClHHI
Ia1.233 or Ib1.233ClHHSCH 3
Ia1.234 or Ib1.234ClHHSCH 2 CH 3
Ia1.235 or Ib1.235ClHHSCO(N(CH 3 ) 2 ) 2
Ia1.236 or Ib1.236ClHHSO 2 CH 3
Ia1.237 or Ib1.237ClHHSO 2 CH 2 CH 3
Ia1.238 or Ib1.238ClHHSC 6 H 5
Ia1.239 or Ib1.239ClHHS(4-CH 3 —C 6 H 4 )
Ia1.240 or Ib1.240ClHHS(4-Cl—C 6 H 4 )
Ia1.241 or Ib1.241ClHHSO 2 C 6 H 5
Ia1.242 or Ib1.242ClHHSO 2 (4-CH 3 —C 6 H 4 )
Ia1.243 or Ib1.243ClHHSO 2 (4-Cl—C 6 H 4 )
Ia1.244 or Ib1.244ClHH4-morpholinyl
Ia1.245 or Ib1.245ClHH1-pyrrolidinyl
Ia1.246 or Ib1.246ClHH1-(1,2,4-triazolyl)
Ia1.247 or Ib1.247ClHH1-imidazolyl
Ia1.248 or Ib1.248ClHH1-pyrazolyl
Ia1.249 or Ib1.249ClHH4-oxo-1,4-dihydro-1-
pyridyl
Ia1.250 or Ib1.250ClHHN(OCH 3 )CH 3
Ia1.251 or Ib1.251ClHH2-tetrahydroisoxazolyl
Ia1.252 or Ib1.252ClHHN(CH 3 )N(CH 3 ) 2
Ia1.253 or Ib1.253ClHHN(CH 2 CH═CH 2 )N(CH 3 ) 2
Ia1.254 or Ib1.254ClHHOPO(OCH 3 ) 2
Ia1.255 or Ib1.255ClHHOPO(OCH 2 CH 3 ) 2
Ia1.256 or Ib1.256ClHHOPO(N(CH 3 ) 2 ) 2
Ia1.257 or Ib1.257ClHHOPO(OC 6 H 5 ) 2
Ia1.258 or Ib1.258ClHHOPO(CH 3 ) 2
Ia1.259 or Ib1.259ClHHOPO(CH 2 CH 3 ) 2
Ia1.260 or Ib1.260ClHHOPO(C 6 H 5 ) 2
Ia1.261 or Ib1.261ClHHOPS(OCH 3 ) 2
Ia1.262 or Ib1.262ClHHOPS(OCH 2 CH 3 ) 2
Ia1.263 or Ib1.263ClHHOP(OCH 3 ) 2
Ia1.264 or Ib1.264ClHHOP(OCH 2 CH 3 ) 2
Ia1.265 or Ib1.265ClHHPO(OCH 3 ) 2
Ia1.266 or Ib1.266ClHHPO(OCH 2 CH 3 ) 2
Ia1.267 or Ib1.267ClHHPO(C 6 H 5 ) 2
Ia1.268 or Ib1.268ClHHOCH 3
Ia1.269 or Ib1.269ClHHOCH 2 CH 3
Ia1.270 or Ib1.270ClHHOCH 2 C 6 H 5
Ia1.271 or Ib1.271ClHHOCH 2 (2-furyl)
Ia1.272 or Ib1.272ClHHOCH 2 (3-furyl)
Ia1.273 or Ib1.273ClHHOCOOCH 3
Ia1.274 or Ib1.274ClHHOCOOCH 2 CH 3
Ia1.275 or Ib1.275ClHHOCOOCH(CH 3 ) 2
Ia1.276 or Ib1.276ClHHOCOOC 6 H 5
Ia1.277 or Ib1.277ClHHOCOOC(CH 3 ) 3
Ia1.278 or Ib1.278ClHHOCSOC 6 H 5
Ia1.279 or Ib1.279ClHHOCSN(CH 3 ) 2
Ia1.280 or Ib1.280ClHHOCON(CH 3 ) 2
Ia1.281 or Ib1.281ClHHOCOSCH 3
Ia1.282 or Ib1.282ClHHON(CH 3 ) 2
Ia1.283 or Ib1.283ClHHO-1-piperidyl
Ia1.284 or Ib1.284ClHHOCOCH 3
Ia1.285 or Ib1.285ClHHOCOCH 2 CH 3
Ia1.286 or Ib1.286ClHHOCOCH(CH 3 ) 2
Ia1.287 or Ib1.287ClHHOCOC(CH 3 ) 3
Ia1.288 or Ib1.288ClHHOCO(CH 2 ) 6 CH 3
Ia1.289 or Ib1.289ClHHOCO(CH 2 ) 7 CH 3
Ia1.290 or Ib1.290ClHHOCO(CH 2 ) 16 CH 3
Ia1.291 or Ib1.291ClHHOCO(CH 2 ) 14 CH 3
Ia1.292 or Ib1.292ClHHOCOCH 2 CH 2 CH═CH 2
Ia1.293 or Ib1.293ClHHOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.294 or Ib1.294ClHHOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.295 or Ib1.295ClHHOCOcyclopropyl
Ia1.296 or Ib1.296ClHHOCOcyclopentyl
Ia1.297 or Ib1.297ClHHOCOcyclohexyl
Ia1.298 or Ib1.298ClHHOCOC 6 H 5
Ia1.299 or Ib1.299ClHHOCO(2-tetrahydrofuryl)
Ia1.300 or Ib1.300ClHHOCO(2-furyl)
Ia1.301 or Ib1.301ClHHOCO(2-thienyl)
Ia1.302 or Ib1.302ClHHOCO(3-pyridyl)
Ia1.303 or Ib1.303ClHHOSO 2 CH 3
Ia1.304 or Ib1.304ClHHOSO 2 CH 2 CH 3
Ia1.305 or Ib1.305CHF 2HHF
Ia1.306 or Ib1.306CHF 2HHCl
Ia1.307 or Ib1.307CHF 2HHBr
Ia1.308 or Ib1.308CHF 2HHI
Ia1.309 or Ib1.309CHF 2HHSCH 3
Ia1.310 or Ib1.310CHF 2HHSCH 2 CH 3
Ia1.311 or Ib1.311CHF 2HHSCO(N(CH 3 ) 2 ) 2
Ia1.312 or Ib1.312CHF 2HHSO 2 CH 3
Ia1.313 or Ib1.313CHF 2HHSO 2 CH 2 CH 3
Ia1.314 or Ib1.314CHF 2HHSC 6 H 5
Ia1.315 or Ib1.315CHF 2HHS(4-CH 3 —C 6 H 4 )
Ia1.316 or Ib1.316CHF 2HHS(4-Cl—C 6 H 4 )
Ia1.317 or Ib1.317CHF 2HHSO 2 C 6 H 5
Ia1.318 or Ib1.318CHF 2HHSO 2 (4-CH 3 —C 6 H 4 )
Ia1.319 or Ib1.319CHF 2HHSO 2 (4-Cl—C 6 H 4 )
Ia1.320 or Ib1.320CHF 2HH4-morpholinyl
Ia1.321 or Ib1.321CHF 2HH1-pyrrolidinyl
Ia1.322 or Ib1.322CHF 2HH1-(1,2,4-triazolyl)
Ia1.323 or Ib1.323CHF 2HH1-imidazolyl
Ia1.324 or Ib1.324CHF 2HH1-pyrazolyl
Ia1.325 or Ib1.325CHF 2HH4-oxo-1,4-dihydro-1-
pyridyl
Ia1.326 or Ib1.326CHF 2HHN(OCH 3 )CH 3
Ia1.327 or Ib1.327CHF 2HH2-tetrahydroisoxazolyl
Ia1.328 or Ib1.328CHF 2HHN(CH 3 )N(CH 3 ) 3
Ia1.329 or Ib1.329CHF 2HHN(CH 2 CH═CH 2 )N(CH 3 ) 2
Ia1.330 or Ib1.330CHF 2HHOPO(OCH 3 ) 2
Ia1.331 or Ib1.331CHF 2HHOPO(OCH 2 CH 3 ) 2
Ia1.332 or Ib1.332CHF 2HHOPO(N(CH 3 ) 2 ) 2
Ia1.333 or Ib1.333CHF 2HHOPO(OC 6 H 5 ) 2
Ia1.334 or Ib1.334CHF 2HHOPO(CH 3 ) 2
Ia1.335 or Ib1.335CHF 2HHOPO(CH 2 CH 3 ) 2
Ia1.336 or Ib1.336CHF 2HHOPO(C 6 H 5 ) 2
Ia1.337 or Ib1.337CHF 2HHOPS(OCH 3 ) 2
Ia1.338 or Ib1.338CHF 2HHOPS(OCH 2 CH 3 ) 2
Ia1.339 or Ib1.339CHF 2HHOP(OCH 3 ) 2
Ia1.340 or Ib1.340CHF 2HHOP(OCH 2 CH 3 ) 2
Ia1.341 or Ib1.341CHF 2HHPO(OCH 3 ) 2
Ia1.342 or Ib1.342CHF 2HHPO(OCH 2 CH 3 ) 2
Ia1.343 or Ib1.343CHF 2HHPO(C 6 H 5 ) 2
Ia1.344 or Ib1.344CHF 2HHOCH 3
Ia1.345 or Ib1.345CHF 2HHOCH 2 CH 3
Ia1.346 or Ib1.346CHF 2HHOCH 2 C 6 H 5
Ia1.347 or Ib1.347CHF 2HHOCH 2 (2-furyl)
Ia1.348 or Ib1.348CHF 2HHOCH 2 (3-furyl)
Ia1.349 or Ib1.349CHF 2HHOCOOCH 3
Ia1.350 or Ib1.350CHF 2HHOCOOCH 2 CH 3
Ia1.351 or Ib1.351CHF 2HHOCOOCH(CH 3 ) 2
Ia1.352 or Ib1.352CHF 2HHOCOOC 6 H 5
Ia1.353 or Ib1.353CHF 2HHOCOOC(CH 3 ) 3
Ia1.354 or Ib1.354CHF 2HHOCSOC 6 H 5
Ia1.355 or Ib1.355CHF 2HHOCSN(CH 3 ) 2
Ia1.356 or Ib1.356CHF 2HHOCON(CH 3 ) 2
Ia1.357 or Ib1.357CHF 2HHOCOSCH 3
Ia1.358 or Ib1.358CHF 2HHON(CH 3 ) 2
Ia1.359 or Ib1.359CHF 2HHO-1-piperidyl
Ia1.360 or Ib1.360CHF 2HHOCOCH 3
Ia1.361 or Ib1.361CHF 2HHOCOCH 2 CH 3
Ia1.362 or Ib1.362CHF 2HHOCOCH(CH 3 ) 2
Ia1.363 or Ib1.363CHF 2HHOCOC(CH 3 ) 3
Ia1.364 or Ib1.364CHF 2HHOCO(CH 2 ) 6 CH 3
Ia1.365 or Ib1.365CHF 2HHOCO(CH 2 ) 7 CH 3
Ia1.366 or Ib1.366CHF 2HHOCO(CH 2 ) 16 CH 3
Ia1.367 or Ib1.367CHF 2HHOCO(CH 2 ) 14 CH 3
Ia1.368 or Ib1.368CHF 2HHOCOCH 2 CH 2 CH═CH 2
Ia1.369 or Ib1.369CHF 2HHOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.370 or Ib1.370CHF 2HHOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.371 or Ib1.371CHF 2HHOCOcyclopropyl
Ia1.372 or Ib1.372CHF 2HHOCOcyclopentyl
Ia1.373 or Ib1.373CHF 2HHOCOcyclohexyl
Ia1.374 or Ib1.374CHF 2HHOCOC 6 H 5
Ia1.375 or Ib1.375CHF 2HHOCO(2-tetrahydrofuryl)
Ia1.376 or Ib1.376CHF 2HHOCO(2-furyl)
Ia1.377 or Ib1.377CHF 2HHOCO(2-thienyl)
Ia1.378 or Ib1.378CHF 2HHOCO(3-pyridyl)
Ia1.379 or Ib1.379CHF 2HHOSO 2 CH 5
Ia1.380 or Ib1.380CHF 2HHOSO 2 CH 2 CH 3
Ia1.381 or Ib1.381ClCH 3HF
Ia1.382 or Ib1.382ClCH 3HCl
Ia1.383 or Ib1.383ClCH 3HBr
Ia1.384 or Ib1.384ClCH 3HI
Ia1.385 or Ib1.385ClCH 3HSCH 3
Ia1.386 or Ib1.386ClCH 3HSCH 2 CH 3
Ia1.387 or Ib1.387ClCH 3HSCO(N(CH 3 ) 2 ) 2
Ia1.388 or Ib1.388ClCH 3HSO 2 CH 3
Ia1.389 or Ib1.389ClCH 3HSO 2 CH 2 CH 3
Ia1.390 or Ib1.390ClCH 3HSC 6 H 5
Ia1.391 or Ib1.391ClCH 3HS(4-CH 3 —C 6 H 4 )
Ia1.392 or Ib1.392ClCH 3HS(4-Cl—C 6 H 4 )
Ia1.393 or Ib1.393ClCH 3HSO 2 C 6 H 5
Ia1.394 or Ib1.394ClCH 3HSO 2 (4-CH 3 —C 6 H 4 )
Ia1.395 or Ib1.395ClCH 3HSO 2 (4-Cl—C 6 H 4 )
Ia1.396 or Ib1.396ClCH 3H4-morpholinyl
Ia1.397 or Ib1.397ClCH 3H1-pyrrolidinyl
Ia1.398 or Ib1.398ClCH 3H1-(1,2,4-triazolyl)
Ia1.399 or Ib1.399ClCH 3H1-imidazolyl
Ia1.400 or Ib1.400ClCH 3H1-pyrazolyl
Ia1.401 or Ib1.401ClCH 3H4-oxo-1,4-dihydro-1-
pyridyl
Ia1.402 or Ib1.402ClCH 3HN(OCH 3 )CH 3
Ia1.403 or Ib1.403ClCH 3H2-tetrahydroisoxazolyl
Ia1.404 or Ib1.404ClCH 3HN(CH 3 )N(CH 3 ) 2
Ia1.405 or Ib1.405ClCH 3HN(CH 2 CH═CH 2 )N(CH 3 ) 2
Ia1.406 or Ib1.406ClCH 3HOPO(OCH 3 ) 2
Ia1.407 or Ib1.407ClCH 3HOPO(OCH 2 CH 3 ) 2
Ia1.408 or Ib1.408ClCH 3HOPO(N(CH 3 ) 2 ) 2
Ia1.409 or Ib1.409ClCH 3HOPO(OC 6 H 5 ) 2
Ia1.410 or Ib1.410ClCH 3HOPO(CH 3 ) 2
Ia1.411 or Ib1.411ClCH 3HOPO(CH 2 CH 3 ) 2
Ia1.412 or Ib1.412ClCH 3HOPO(C 6 H 5 ) 2
Ia1.413 or Ib1.413ClCH 3HOPS(OCH 3 ) 2
Ia1.414 or Ib1.414ClCH 3HOPS(OCH 2 CH 3 ) 2
Ia1.415 or Ib1.415ClCH 3HOP(OCH 3 ) 2
Ia1.416 or Ib1.416ClCH 3HOP(OCH 2 CH 3 ) 2
Ia1.417 or Ib1.417ClCH 3HPO(OCH 3 ) 2
Ia1.418 or Ib1.418ClCH 3HPO(OCH 2 CH 3 ) 2
Ia1.419 or Ib1.419ClCH 3HPO(C 6 H 5 ) 2
Ia1.420 or Ib1.420ClCH 3HOCH 3
Ia1.421 or Ib1.421ClCH 3HOCH 2 CH 3
Ia1.422 or Ib1.422ClCH 3HOCH 2 C 6 H 5
Ia1.423 or Ib1.423ClCH 3HOCH 2 (2-furyl)
Ia1.424 or Ib1.424ClCH 3HOCH 2 (3-furyl)
Ia1.425 or Ib1.425ClCH 3HOCOOCH 3
Ia1.426 or Ib1.426ClCH 3HOCOOCH 2 CH 3
Ia1.427 or Ib1.427ClCH 3HOCOOCH(CH 3 ) 2
Ia1.428 or Ib1.428ClCH 3HOCOOC 6 H 5
Ia1.429 or Ib1.429ClCH 3HOCOOC(CH 3 ) 3
Ia1.430 or Ib1.430ClCH 3HOCSOC 6 H 5
Ia1.431 or Ib1.431ClCH 3HOCSN(CH 3 ) 2
Ia1.432 or Ib1.432ClCH 3HOCON(CH 3 ) 2
Ia1.433 or Ib1.433ClCH 3HOCOSCH 3
Ia1.434 or Ib1.434ClCH 3HON(CH 3 ) 2
Ia1.435 or Ib1.435ClCH 3HO-1-piperidyl
Ia1.436 or Ib1.436ClCH 3HOCOCH 3
Ia1.437 or Ib1.437ClCH 3HOCOCH 2 CH 3
Ia1.438 or Ib1.438ClCH 3HOCOCH(CH 3 ) 2
Ia1.439 or Ib1.439ClCH 3HOCOC(CH 3 ) 3
Ia1.440 or Ib1.440ClCH 3HOCO(CH 2 ) 6 CH 3
Ia1.441 or Ib1.441ClCH 3HOCO(CH 2 ) 7 CH 3
Ia1.442 or Ib1.442ClCH 3HOCO(CH 2 ) 16 CH 3
Ia1.443 or Ib1.443ClCH 3HOCO(CH 2 ) 14 CH 3
Ia1.444 or Ib1.444ClCH 3HOCOCH 2 CH 2 CH═CH 2
Ia1.445 or Ib1.445ClCH 3HOCO(CH 2 ) 3 O(2,4-Cl 2 —C 6 H 3 )
Ia1.446 or Ib1.446ClCH 3HOCOCH(CH 3 )O—
(2-CH 3 -4-Cl—C 6 H 3 )
Ia1.447 or Ib1.447ClCH 3HOCOcyclopropyl
Ia1.448 or Ib1.448ClCH 3HOCOcyclopentyl
Ia1.449 or Ib1.449ClCH 3HOCOcyclohexyl
Ia1.450 or Ib1.450ClCH 3HOCOC 6 H 5
Ia1.451 or Ib1.451ClCH 3HOCO(2-tetrahydrofuryl)
Ia1.452 or Ib1.452ClCH 3HOCO(2-furyl)
Ia1.453 or Ib1.453ClCH 3HOCO(2-thienyl)
Ia1.454 or Ib1.454ClCH 3HOCO(3-pyridyl)
Ia1.455 or Ib1.455ClCH 3HOSO 2 CH 3
Ia1.456 or Ib1.456ClCH 3HOSO 2 CH 2 CH 3
TABLE 2 — Ia
No.R 1R 2R 3R 5(R 6 ) 1m.p. [° C.] or 1 H-NMR [ppm]
2.1FHHOCOC 6 H 54,4,6,6-(CH 3 ) 4 -5-oxo178
2.2FHHOCOC(CH 3 ) 34,4,6,6-(CH 3 ) 4 -5-oxo9.22(d, 1H); 9.03(d, 1H); 7.98(q,
1H); 7.62(q, 1H); 7.39(t, 1H); 1.49
(s, 6H); 1.40(s, 6H); 1.11(s, 9H)
2.3ClHHOCOC 6 H 54,4,6,6-(CH 3 ) 4 -5-oxo>200
2.4ClHHOCOC(CH 3 ) 34,4,6,6-(CH 3 ) 4 -5-oxo9.20(dd, 2H); 8.85(q, 2H); 7.60(q,
1H); 1.40(s, 12H); 1.12(s, 9H)
2.5CH 3HHOPS(OCH 2 CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo9.50(d, 1H); 8.98(d, 1H); 8.06(d,
1H); 7.60(m, 2H); 3.95(m, 4H); 2.90
(s, 3H); 1.65(s, 6H); 1.51(s, 6H)
2.6CH 3HHOCOSCH 34,4,6,6-(CH 3 ) 4 -5-oxo128
2.7CH 3HHOCSN(CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo163
2.8CH 3HHOCOC 6 H 54,4,6,6-(CH 3 ) 4 -5-oxo9.05(d, 1H); 9.85(d, 1H); 7.92(d,
1H); 7.72(d, 2H); 7.51(d, 1H); 7.48
(t, 1H); 7.35(q, 1H); 7.28(t, 2H);
2.79(s, 3H); 1.62(s, 6H); 1.55(s, 6H)
2.9CH 3HHOPO[N(CH 3 ] 24,4,6,6-(CH 3 ) 4 -5-oxo9.41(d, 1H); 8.95(d, 1H); 8.07(d,
1H); 7.58(d, 1H); 7.50(q, 1H); 2.88
(s, 3H); 2.45(s, 6H); 2.42(s, 6H);
1.65(s, 6H); 1.48(s, 6H)
2.10CH 3HHOCO(CH 2 ) 3 O(2,4-4,4,6,6-(CH 3 ) 4 -5-oxooil
Cl2-C 6 H 3 )
2.11CH 3HHOCOCH(CH 3 )O(2-CH 3 -4,4,6,6-(CH 3 ) 4 -5-oxooil
4-Cl—C 6 H 3 )
2.12CH 3HHOCOC(CH 3 ) 34,4,6,6-(CH 3 ) 4 -5-oxo9.20(d, 1H); 8.85(d, 1H); 7.80(d,
1H); 7.51(d, 1H); 7.48(q, 1H); 2.85
(s, 3H); 1.55(s, 6H); 1.50(s, 6H);
1.08(s, 9H)
2.13FHHOCOC(CH 3 ) 34,4,6-(CH 3 ) 3oil
2.14ClHHOCOCH 2 CH 34,4,6,6-(CH 3 ) 4 -5-oxo9.13(d, 1H); 9.02(d, 1H); 7.85(s,
2H); 7.58(q, 1H); 2.40(q, 2H); 1.60
(s, 6H); 1.50(s, 6H); 1.05(t, 3H)
2.15FHHOCOSCH 34,4,6,6-(CH 3 ) 4 -5-(OH)190–192
2.16ClHHOCOSCH 34,4,6,6-(CH 3 ) 4 -5-oxo84
2.17FHHOCOSCH 34,4,6,6-(CH 3 ) 4 -5-oxo72
2.18CH 3HHOCH 34,4,6,6-(CH 3 ) 4 -5-oxo9.44(d, 1H); 9.03(d, 1H); 7.88(d,
1H); 7.59(m, 2H); 3.92(s, 3H); 2.90
(s, 3H); 1.50(s, 6H); 1.38(s, 6H)
2.19FHHOSO 2 CH 34,4,6,6-(CH 3 ) 4 -5-(OH)9.30(d, 1H); 9.02(d, 1H); 7.93(q,
1H); 7.61(q, 1H); 7.40(q, 1H); 3.01
(s, 3H); 1.57(s, 3H); 1.53(s, 3H);
1.32(s, 3H); 1.28(s, 3H)
2.20FHHOCOOCH 2 CH 34,4,6,6-(CH 3 ) 4 -5-9.18(d, 1H); 9.02(s, 1H); 7.92(q,
(OCOOCH 2 CH 3 )1H); 7.65(q, 1H); 7.41(q, 1H); 4.32
(q, 2H); 4.11(q, 1H); 1.45(s, 3H);
1.40(s, 3H); 1.38(s, 3H); 1.30(s,
3H); 1.22(s, 3H); 1.15(s, 3H)
2.21FHHOCH 34,4,6,6-(CH 3 ) 4 -5-oxo9.45(d, 1H); 9.03(d, 1H); 7.96(q,
1H); 7.68(q, 1H); (7.40(t, 1H);
3.88(s, 3H); 1.50(s, 6H); 1.39(s, 6H)
2.22ClHHCl4,4,6,6-(CH 3 ) 4 -5-oxo180
2.23FHHCl4,4,6,6-(CH 3 ) 4 -5-oxo152
2.24ClHHS(4-CH 3 —C 6 H 4 )4,4,6,6-(CH 3 ) 4 -5-oxo119
2.25S(4-CH 3 —HHS(4-CH 3 —C 6 H 4 )4,4,6,6-(CH 3 ) 4 -5-oxo132–135
C 6 H 4 )
2.26ClHHCl4,4,6,6-(CH 3 ) 4 -5-oxo
2.27O(tetra-HHCl4,4,6,6-(CH 3 ) 4 -5-oxo9.65(d, 1H); 9.05(d, 1H); 8.83(d,
hydro-1H); 7.66(q, 1H); 6.95(d, 1H); 5.23
furan-(m, 1H); 4.21(d, 2H); 4.05(m, 2H);
3-yl)2.39(m, 2H); 1.62(s, 6H); 1.48(s, 6H)
2.28CH 3HHCl4,4,6,6-(CH 3 ) 4 -5-oxo194
2.29FHHCl4,4,6-(CH 3 ) 3oil
2.30CH 3HHBr4,4,6,6-(CH 3 ) 4 -5-oxooil
2.31CHF 2HHCl4,4,6,6-(CH 3 ) 4 -5-oxo9.40(d, 1H); 9.05(d, 1H); 8.05(d,
1H); 7.86(t, 1H); 7.80(d, 1H); 7.65
(q, 1H); 1.59(s, 6H); 1.48(s, 6H)
2.32CF 3HHCl4,4,6,6-(CH 3 ) 4 -5-oxooil
2.33CF 3CH 3HCl5,5-(CH 3 ) 29.15(d, 1H); 8.10(d, 1H); 7.75(d,
1H); 7.52(d, 1H); 3.02(s, 2H); 2.91
(s, 2H); 2.80(s, 3H); 1.20(s, 6H)
2.34CH 3HHN(CH 3 )OCH 34,4,6,6-(CH 3 ) 4 -5-oxooil
2.35CH 3HHSCH 34,4,6,6-(CH 3 ) 4 -5-oxo9.50(d, 1H); 9.02(d, 1H); 7.80(d,
1H); 7.50(m, 3H); 2.90(s, 3H); 2.30
(s, 3H); 1.50(s, 6H); 1.35(s,3H);
1.25(s, 3H)
2.36ClHH1-pyrazolyl4,4,6,6-(CH 3 ) 4 -5-oxo9.30(d, 1H); 9.05(d, 1H); 7.80(d,
1H); 7.75(d, 1H); 7.61(q, 1H); 7.52
(d, 1H); 7.40(s, 1H); 6.11(s, 1H);
1.65(s, 3H); 1.60(s, 3H); 1.50(s, 6H)
2.37ClHHN(CH 3 )OCH 34,4,6,6-(CH 3 ) 4 -5-oxo190
2.38CH 3HH1-pyrolidinyl4,4,6,6-(CH 3 ) 4 -5-oxooil
2.39CH 3HH4-morpholinyl4,4,6,6-(CH 3 ) 4 -5-oxo205
2.40ClHH4-morpholinyl4,4,6,6-(CH 3 ) 4 -5-oxo205
2.41CH 3HHCl4,4,6,6-(CH 3 ) 4 -5-oxo194
2.42CH 3HH1-pyrazolyl4,4,6,6-(CH 3 ) 4 -5-oxo150
2.43CF 3HH4-morpholinyl4,4,6,6-(CH 3 ) 4 -5-oxooil
2.44CHNOCH 3HHCl4,4,6,6-(CH 3 ) 4 -5-oxooil
2.45ClHHSCON(CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo138
2.46ClHH4-oxo-1,4-dihydro-4,4,6,6-(CH 3 ) 4 -5-oxo>210
pyrid-1-yl
2.47FHHCl4,6-(CH 3 ) 2 -4-SCH 3oil
2.48CH 3HHSCON(CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo166
2.49CH 3HHOP(OCH 2 CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo9.65(d, 1H); 8.97(d, 1H); 7.79(d,
1H); 7.60(m, 2H); 4.00(m, 4H); 2.91
(s, 3H); 1.71(s, 6H); 1.51(s, 6H)
2.50OCH 3HHCl4,4,6,6-(CH 3 ) 4 -5-oxo9.65(d, 1H); 9.01(d, 1H); 7.83(d,
1H); 7.65(q, 1H); 7.02(d, 1H); 4.18
(s, 3H); 1.65(s, 6H); 1.55(s, 6H)
2.51FHHOCOS(CH 2 ) 7 CH 34,4,6,6-(CH 3 ) 4 -5-oxo9.20((d, 1H); 9.02(d, 1H); 7.89
(q, 1H); 7.60(q, 1H); 7.40(t,
1H); 2.62(t, 2H); 1.55(s, 6H);
1.48(s, 6H); 1.1–1.5(m, 12H);
0.85(t, 3H)
2.52FHHCl4,6-(ethan-1,2-diyl) 1)9.55(d, 1H); 9.02(d, 1H); 7.78
(q, 1H); 7.65(q, 1H); 7.40(t,
1H); 3.24(m, 1H); 3.17(m, 1H);
2.41(d, 1H); 1.8–2.4(m, 5H)
2.53SCH 3HHOCOSCH 34,4,6,6-(CH 3 ) 4 -5-oxo147
2.54FHHOCOSCH 2 CH 34,4,6,6-(CH 3 ) 4 -5-oxo107
2.55BrHHOCOC(CH 3 ) 34,4,6,6-(CH 3 ) 4 -5-oxo134
2.56BrHHOCO(C 6 H 5 )4,4,6,6-(CH 3 ) 4 -5-oxo228
2.57ClHHF4,4,6,6-(CH 3 ) 4 -5-oxo181
2.58FHHSO 2 CH 34,4,6,6-(CH 3 ) 4 -5-oxo206
2.59FHHSOCH 34,4,6,6-(CH 3 ) 4 -5-oxo190
2.60SCH 2 FHHF4,4,6,6-(CH 3 ) 4 -5-oxo9.50(d, 1H); 9.00(d, 1H); 7.81
(s, 2H); 7.65(g, 1H); 6.01(d,
2H); 1.60(s, 6H); 1.51(s, 6H)
2.61FHHSC 6 H 54,4,6,6-(CH 3 ) 4 -5-oxo65
2.62FHHSO 2 C 6 H 54,4,6,6-(CH 3 ) 4 -5-oxo111
2.63FHHSCH 34,4,6,6-(CH 3 ) 4 -5-oxo143
2.64CHF 2HHF4,4,6,6-(CH 3 ) 4 -5-oxo183
2.65ClCHF 2HF4,4,6,6-(CH 3 ) 4 -5-oxo173
2.66FHHF4,4,6,6-(CH 3 ) 4 -5-oxo153
1) R 4 = 4-Oxo-(bicyclo[3.2.1]oct-2-en-3-yl)carbonyl
TABLE 3 — Ib
No.R 1R 2R 3R 5R 6m.p. [° C.] or 1 H-NMR [ppm]
3.1ClHHCl4,4,6,6-(CH 3 ) 4 -5-oxo156
3.2CH 3HH1-(1,2,4-triazolyl)4,4,6,6-(CH 3 ) 4 -5-oxo9.00(d, 1H); 8.09(s, 1H); 7.82(d,
1H); 7.72(s, 1H); 7.68(d, 1H); 7.47
(d, 1H); 7.35(q, 1H); 2.95(s, 3H);
1.55(s, 6H); 1.30(s, 6H)
3.3ClHH4-morpholinyl4,4,6,6-(CH 3 ) 4 -5-oxo9.15(d, 1H); 8.32(d, 1H); 7.82(d,
1H); 7.60(q, 1H); 7.45(d, 1H); 4.05
(m, 2H); 3.68(m, 4H); 3.35(m, 1H);
3.25(m, 1H); 1.30(s, 6H); 1.22(s, 6H)
3.4ClHHSCON(CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo75
3.5ClHH4-oxo-1,4-dihydro-4,4,6,6-(CH 3 ) 4 -5-oxo9.02(d, 1H); 8.42(d, 1H); 7.80(2d,
pyrid-1-yl3H); 7.50(q, 1H); 7.38(d, 1H); 6.72
(d, 2H); 1.50(s, 12H)
3.6ClHHN(CH 3 ) 24,4,6,6-(CH 3 ) 4 -5-oxo190
10 of 21 part labels are ours — the grant heads the rest

Claims as granted

23 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

23 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01N43/56
  • A01N43/42
  • A01N47/18
  • A01N25/00
  • A01N57/28
  • A01N43/653
  • A01N57/12
  • A01N43/84
  • A01N43/40
Section C — Chemistry; metallurgy
  • C07D215/14
  • C07F9/60
  • C07D215/18
  • C07D215/36
  • C07D405/12
  • C07D401/06
  • C07D215/12
  • C07D413/06
  • C07D401/08
  • C07D401/12
  • C07D409/12
USPC · US Patent Classification
504/247546/173546/152

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom2000200120022003200420052006USPTOApplicantRestriction requirementNon-final rejectionNon-final rejectionResponse after non-finalNotice of appeal filedResponse after non-finalResponse after final
USPTOApplicanthover for detail · click to open
Pendency
6.6 y
2,426 days filing → grant
Office actions
5
after a restriction
Responses
5
1 RCE
Examiner
Celia Chang
art unit 1625 · TC 1600
Citations: 8 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2002200420062008201020122014201620182020Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock